{"PMC7169754": [["INTRODUCTIONThe incidence of skin and soft tissue infections (SSTI) due to multi\u2010drug resistant (MDR) pathogens is continuing to rise.1 As a result, antibiotic use has increased in parallel to this trend.", [["skin", "ANATOMY", 29, 33], ["soft tissue", "ANATOMY", 38, 49], ["skin and soft tissue infections", "DISEASE", 29, 60], ["SSTI", "DISEASE", 62, 66], ["multi\u2010drug resistant (MDR) pathogens", "DISEASE", 75, 111], ["skin", "ORGAN", 29, 33], ["soft tissue", "TISSUE", 38, 49], ["skin and soft tissue infections", "PROBLEM", 29, 60], ["SSTI", "PROBLEM", 62, 66], ["multi\u2010drug resistant (MDR) pathogens", "PROBLEM", 75, 111], ["antibiotic use", "TREATMENT", 149, 163], ["skin", "ANATOMY", 29, 33], ["soft tissue", "OBSERVATION_MODIFIER", 38, 49], ["infections", "OBSERVATION", 50, 60], ["increased", "OBSERVATION_MODIFIER", 168, 177]]], ["For example, a population\u2010based study in Canada demonstrated a 15% increase in physician visits for SSTI and an associated 49% increase in antibiotic prescriptions between 1996 and 2008.2 Unfortunately, increasing antibiotic use has become a major driving force in the development of resistant organisms, undermining their very purpose.3", [["SSTI", "DISEASE", 100, 104], ["a population\u2010based study", "TEST", 13, 37], ["SSTI", "PROBLEM", 100, 104], ["antibiotic prescriptions", "TREATMENT", 139, 163], ["increasing antibiotic use", "TREATMENT", 203, 228], ["resistant organisms", "PROBLEM", 284, 303], ["increasing", "OBSERVATION_MODIFIER", 203, 213], ["antibiotic", "OBSERVATION", 214, 224]]]], "PMC7201199": [["IntroductionTo date, the literatures on urbanisation and globalisation have focused primarily oneconomic and demographic flows to, from and through cities and their regions (Brenner, 2014; Ren and Keil, 2017).", [["demographic flows", "TEST", 109, 126]]], ["Morerecently, there has been a growing academic and policy interest in connectingchallenges of a majority urbanised world to questions of health and disease,including Ali and Keil\u2019s(2008) edited collection, Networked Disease: Emerging Infectionsin the Global City, as a ground-breaking publication (see also Elsey et al., 2019; Moore et al., 2003; Wu et al., 2017).", [["disease", "PROBLEM", 149, 156], ["Ali", "PROBLEM", 167, 170], ["growing", "OBSERVATION_MODIFIER", 31, 38]]], ["MeikeWolf\u2019s (2016)research on urban epidemiology also takes forward the debate surrounding the role ofchanging geographies on urban health and disease.", [["disease", "PROBLEM", 143, 150]]], ["Recognisingthese emerging conversations, we are specifically interested in this paper in newways in which infectious disease is bound up with processes ofextended urbanisation, paying particular attention to thesocio-ecological flows and disruptions leading to an increased incidence ofinfectious disease in peri- or suburban areas.IntroductionThis paper, then, will focus on the impact that more extensive forms of urbanisationworldwide have on increasing susceptibility to infectious disease, especiallyemerging infectious disease (EID), that is, \u2018an infectious disease whose incidenceis increasing following its first introduction into a new host population\u2019 (Quammen, 2012: 43), andzoonosis, which is \u2018an animal infection transmissible to humans\u2019 (Quammen, 2012: 14).Notably, ecological pressures coupled with social and spatial change have led to newforms of disease spread that have likewise contributed to the rise of EID epidemics.These include changes in water-borne EID spread, as was the case with E.coli 0157:H7 (Ali,2004); changes in food-borne EID transmission as brought on by changes inglobal consumption patterns (Hoffman, 2014); as well as changes in the distribution of vector-bornediseases such as malaria, wherein the distribution of mosquitos has been affected byglobal climate change (Brisboisand Ali, 2010; Epstein, 1998; Nading, 2014).IntroductionIn examining these relationships between extended urbanisation and infectious diseasewe suggest how a landscape political ecology (LPE) framework can be useful forintegrating the key themes of spatiality, socio-natural metabolism and powerrelations central to undertaking such an analysis.", [["infectious disease", "DISEASE", 106, 124], ["infectious disease", "DISEASE", 475, 493], ["infectious disease", "DISEASE", 514, 532], ["EID", "DISEASE", 534, 537], ["infectious disease", "DISEASE", 553, 571], ["incidenceis", "DISEASE", 578, 589], ["andzoonosis", "DISEASE", 683, 694], ["infection transmissible to humans\u2019", "DISEASE", 716, 750], ["malaria", "DISEASE", 1218, 1225], ["mosquitos", "DISEASE", 1255, 1264], ["humans", "ORGANISM", 743, 749], ["humans", "SPECIES", 743, 749], ["humans", "SPECIES", 743, 749], ["disruptions", "PROBLEM", 238, 249], ["an increased incidence ofinfectious disease", "PROBLEM", 261, 304], ["increasing susceptibility to infectious disease", "PROBLEM", 446, 493], ["\u2018an infectious disease", "PROBLEM", 549, 571], ["ecological pressures", "TEST", 780, 800], ["disease spread", "PROBLEM", 864, 878], ["E.coli", "TEST", 1009, 1015], ["changes in food", "PROBLEM", 1036, 1051], ["vector-bornediseases", "PROBLEM", 1189, 1209], ["malaria", "PROBLEM", 1218, 1225], ["IntroductionIn", "TREATMENT", 1360, 1374], ["an analysis", "TEST", 1649, 1660], ["increased", "OBSERVATION_MODIFIER", 264, 273], ["incidence", "OBSERVATION_MODIFIER", 274, 283], ["ofinfectious", "OBSERVATION_MODIFIER", 284, 296], ["disease", "OBSERVATION", 297, 304], ["infection", "OBSERVATION", 716, 725], ["pressures", "OBSERVATION_MODIFIER", 791, 800], ["malaria", "OBSERVATION", 1218, 1225]]], ["We posit that, while rapid and intensive forms ofurbanisation (densification) are seen as enabling factors for the spread ofinfectious disease (Munster etal., 2018), it is important to study extended urbanisation becausepatterns of urban sprawl and expansion are more likely to lead to infectious diseaseoutbreaks, as opposed to cities, which are generally assumed to reduce the incidenceof infectious disease for inhabitants (see Wood et al., 2017).", [["diseaseoutbreaks", "DISEASE", 297, 313], ["infectious disease", "DISEASE", 391, 409], ["the spread ofinfectious disease", "PROBLEM", 111, 142], ["infectious diseaseoutbreaks", "PROBLEM", 286, 313], ["the incidenceof infectious disease", "PROBLEM", 375, 409], ["more likely", "UNCERTAINTY", 263, 274], ["infectious", "OBSERVATION", 286, 296]]], ["This is, in part,because urban expansion might expose sub- and ex-urban areas to higher levels ofbiodiversity (and disease sources) than are found in central urban areas (Kaup, 2018).", [["urban expansion", "PROBLEM", 25, 40], ["higher levels ofbiodiversity", "PROBLEM", 81, 109], ["disease sources", "PROBLEM", 115, 130], ["sub", "OBSERVATION_MODIFIER", 54, 57], ["higher levels", "OBSERVATION_MODIFIER", 81, 94], ["central", "ANATOMY_MODIFIER", 150, 157]]], ["Cities alsohave better health facilities and resources which can enable faster response timesand enhance containment of disease outbreaks.IntroductionIn other words, the new and evolving global peripheries have been particularlysusceptible to diseases that jump the animal-to-human species boundary (zoonosis);have seen the introduction of new disease vectors; and have seen dynamic changes tourban and spatial morphology and transformations over time (Brisbois and Ali, 2010).", [["zoonosis", "DISEASE", 300, 308], ["human", "ORGANISM", 276, 281], ["human", "SPECIES", 276, 281], ["disease outbreaks", "PROBLEM", 120, 137], ["diseases", "PROBLEM", 243, 251], ["new disease vectors", "PROBLEM", 340, 359], ["spatial morphology", "OBSERVATION_MODIFIER", 403, 421]]], ["In demonstratingthis argument, we highlight three key factors influencing the distribution ofinfectious disease burden that have been identified in the literature on this topicwithin various strands of urban studies.", [["the distribution ofinfectious disease burden", "PROBLEM", 74, 118], ["urban studies", "TEST", 202, 215]]], ["These interrelated dimensions are mobilityand demographic change, infrastructure and governance.", [["dimensions", "OBSERVATION_MODIFIER", 19, 29]]], ["There are certainly morefactors that could be identified (e.g. deforestation and climate change) but thesethree themes have been most prominent in the literature on urbanisation andinfectious disease, and also relate closely to processes of extendedurbanisation.1 We have kept these themes intentionally broad to capture as muchof the disparate work that exists on this topic as possible.", [["extendedurbanisation", "DISEASE", 241, 261], ["certainly morefactors", "PROBLEM", 10, 31], ["urbanisation andinfectious disease", "PROBLEM", 165, 199], ["extendedurbanisation", "PROBLEM", 241, 261], ["could be", "UNCERTAINTY", 37, 45], ["most prominent", "OBSERVATION_MODIFIER", 129, 143], ["extendedurbanisation", "OBSERVATION", 241, 261]]], ["Moreover, we considerhow these factors influence different phases of infectious disease management, fromdisease prevention to mitigation and control of outbreaks, and possibleresponses.IntroductionIn what follows we will first establish the context for this paper, outlining why therelationship between extended urbanisation and infectious disease is important tostudy, and how this differs from existing work on the relationship betweenurbanisation and disease.", [["infectious disease", "DISEASE", 329, 347], ["infectious disease management", "TREATMENT", 69, 98], ["fromdisease prevention", "TREATMENT", 100, 122], ["mitigation", "TREATMENT", 126, 136], ["outbreaks", "PROBLEM", 152, 161], ["disease", "PROBLEM", 454, 461], ["infectious", "OBSERVATION_MODIFIER", 69, 79], ["infectious", "OBSERVATION", 329, 339]]], ["Subsequently, we introduce the conceptual framework oflandscape political ecology, indicating how this relates to (but differs from) urbanpolitical ecology and how this is a useful lens through which to understand theemergence of infectious disease in peri-urban areas.", [["infectious disease", "DISEASE", 230, 248], ["infectious disease in peri-urban areas", "PROBLEM", 230, 268], ["infectious", "OBSERVATION", 230, 240]]], ["Finally, we reflect on how the expansion of the city caninfluence the spread of disease and how this can be addressed in futureresearch.Chronic and (emerging) infectious disease ::: Extended urbanisation and emerging infectious diseaseBefore we continue, we need to acknowledge that much of the debate abouturbanisation or, more precisely, extended urbanisation and health/disease isoccupied by a burgeoning interest in chronic diseases associated with alifestyle that is ascribed to suburbanisation, auto-mobility and relatedtechnologies.", [["Chronic and (emerging) infectious disease", "DISEASE", 136, 177], ["chronic diseases", "DISEASE", 420, 436], ["disease", "PROBLEM", 80, 87], ["chronic diseases", "PROBLEM", 420, 436], ["alifestyle", "TREATMENT", 453, 463], ["auto-mobility and relatedtechnologies", "PROBLEM", 501, 538], ["disease", "OBSERVATION", 80, 87], ["infectious", "OBSERVATION", 159, 169], ["infectious", "OBSERVATION_MODIFIER", 217, 227], ["chronic", "OBSERVATION_MODIFIER", 420, 427], ["diseases", "OBSERVATION", 428, 436]]], ["At the top of the list of these concerns are usually obesity(especially amongst young people), diabetes and heart disease (Hamblin, 2014).Importantly, attention has now also shifted to mental health related to suburbanlife, for example in emerging work on people living with dementia in suburbanenvironments (Biglieri,2018).", [["heart", "ANATOMY", 108, 113], ["obesity", "DISEASE", 53, 60], ["diabetes", "DISEASE", 95, 103], ["heart disease", "DISEASE", 108, 121], ["dementia", "DISEASE", 275, 283], ["people", "ORGANISM", 86, 92], ["heart", "ORGAN", 108, 113], ["people", "ORGANISM", 256, 262], ["people", "SPECIES", 86, 92], ["people", "SPECIES", 256, 262], ["usually obesity", "PROBLEM", 45, 60], ["diabetes", "PROBLEM", 95, 103], ["heart disease", "PROBLEM", 108, 121], ["dementia", "PROBLEM", 275, 283], ["obesity", "OBSERVATION", 53, 60], ["heart", "ANATOMY", 108, 113], ["disease", "OBSERVATION", 114, 121]]], ["Much of the literature on chronic disease has, as the tacitstarting point, the notion of \u2018epidemiological transition\u2019.", [["chronic disease", "DISEASE", 26, 41], ["chronic disease", "PROBLEM", 26, 41], ["chronic", "OBSERVATION_MODIFIER", 26, 33], ["disease", "OBSERVATION", 34, 41]]], ["That is, theargument that in Western, industrialised societies, more individuals are livingto older ages, which consequently leads to increased incidence and prevalence ofchronic diseases associated with (sedentary) \u2018lifestyle\u2019 and \u2018ageing\u2019, asopposed to infectious diseases.", [["infectious diseases", "DISEASE", 255, 274], ["prevalence ofchronic diseases", "PROBLEM", 158, 187], ["infectious diseases", "PROBLEM", 255, 274]]], ["Bloch and co-authors (2013: 96) ofcourse warn: \u2018A closer examination of urban risk shows, in fact, that \u201csprawl\u201dis not the problem, but rather the lack of adequate land use planning policiesand infrastructure provision in rapidly growing and expanding settlements.\u2019Chronic and (emerging) infectious disease ::: Extended urbanisation and emerging infectious diseaseOne of the key points of emphasis in approaches based on this premise is a focuson the physical environment found within such contexts.", [["infectious disease", "DISEASE", 288, 306], ["A closer examination", "TEST", 48, 68], ["Chronic", "OBSERVATION_MODIFIER", 265, 272], ["urbanisation", "OBSERVATION_MODIFIER", 320, 332], ["infectious", "OBSERVATION_MODIFIER", 346, 356]]], ["However,such findings are not wholly conclusive, as research has also pointed to certainfeatures of urban life that benefit the health of urban dwellers, including theavailability of social support and better access to health and social services(Bollyky, 2019).Current health research does conclusively demonstrate, however, that one aspectof the built environment is detrimental to good health, namely, living insprawling suburban neighbourhoods (Freudenberg et al., 2005; Frumkin et al., 2004).What has made this question more complicated is exactly the tendency, invoked inour usage of extended urbanisation and post-suburbanisation, of blurring theclassical lines of distinction of city and suburb, town and country.", [["social support", "TREATMENT", 183, 197], ["blurring theclassical lines", "PROBLEM", 640, 667]]], ["It appearsmore important for the health of communities and individuals where in the worldand, indeed, where in the urban region they are located and how those particularareas are changing in relation to their natural and social environments (Wilson et al.,2008).Chronic and (emerging) infectious disease ::: Extended urbanisation and emerging infectious diseaseAs alluded to above, the tendency to date not to have focused concerted attentionon infectious disease may have to do with the \u2018epidemiological transition\u2019model.", [["Chronic and (emerging) infectious disease", "DISEASE", 262, 303], ["infectious disease", "DISEASE", 343, 361], ["infectious disease", "DISEASE", 445, 463], ["emerging infectious disease", "PROBLEM", 334, 361], ["focused concerted attentionon infectious disease", "PROBLEM", 415, 463], ["the \u2018epidemiological transition\u2019model", "TREATMENT", 484, 521], ["infectious", "OBSERVATION", 285, 295], ["infectious", "OBSERVATION", 343, 353]]], ["According to this perspective, Western societies have undergone a healthtransition whereupon infectious diseases were no longer to be considered asmajor causes of mortality and morbidity (Omran, 1971).", [["infectious diseases", "DISEASE", 93, 112], ["infectious diseases", "PROBLEM", 93, 112], ["morbidity", "PROBLEM", 177, 186]]], ["Thus, for example, it wasin this light that in 1967 the US Surgeon General publicly declared that it was\u2018time to close the books on infectious diseases\u2019 and to shift all nationalattention to chronic diseases such as cardiovascular disease (Garrett, 1994: 33).Recent developments, however, appear to indicate that this may be premature aswe now appear to face an onslaught of what are referred to as new and(re)emerging diseases (Garrett, 1994; Haggett, 1994; Mayer, 2000; Morse, 1996).Chronic and (emerging) infectious disease ::: Extended urbanisation and emerging infectious diseaseEmerging diseases are those which have become more prevalent during the lastquarter century, while \u2018new diseases\u2019 refers not only to newly appearing onesbut also to those that are spreading to new geographical areas (Mayer, 2000).", [["cardiovascular", "ANATOMY", 216, 230], ["infectious diseases", "DISEASE", 132, 151], ["chronic diseases", "DISEASE", 191, 207], ["cardiovascular disease", "DISEASE", 216, 238], ["Chronic and (emerging) infectious disease", "DISEASE", 485, 526], ["infectious diseaseEmerging diseases", "DISEASE", 566, 601], ["cardiovascular", "ANATOMICAL_SYSTEM", 216, 230], ["infectious diseases", "PROBLEM", 132, 151], ["chronic diseases", "PROBLEM", 191, 207], ["cardiovascular disease", "PROBLEM", 216, 238], ["premature aswe", "PROBLEM", 325, 339], ["emerging infectious diseaseEmerging diseases", "PROBLEM", 557, 601], ["infectious", "OBSERVATION", 132, 142], ["chronic", "OBSERVATION_MODIFIER", 191, 198], ["diseases", "OBSERVATION", 199, 207], ["cardiovascular", "ANATOMY", 216, 230], ["infectious", "OBSERVATION", 508, 518], ["urbanisation", "OBSERVATION_MODIFIER", 540, 552], ["infectious", "OBSERVATION_MODIFIER", 566, 576], ["more prevalent", "OBSERVATION_MODIFIER", 630, 644], ["new", "OBSERVATION_MODIFIER", 777, 780]]], ["Someexamples of these include: yellow fever, the Marburg virus, Legionnaires\u2019disease, the Ebola virus, Lyme disease, hepatitis C, HIV/AIDS, Hantaviruspulmonary syndrome, West Nile virus and Severe Acute Respiratory Syndrome (Drexler, 2002; Garrett, 1994; Heymann and Rodier,1997).", [["yellow fever", "DISEASE", 31, 43], ["Marburg virus", "DISEASE", 49, 62], ["Legionnaires\u2019disease", "DISEASE", 64, 84], ["Ebola virus", "DISEASE", 90, 101], ["Lyme disease", "DISEASE", 103, 115], ["hepatitis C", "DISEASE", 117, 128], ["HIV/AIDS", "DISEASE", 130, 138], ["Hantaviruspulmonary syndrome", "DISEASE", 140, 168], ["West Nile virus", "DISEASE", 170, 185], ["Acute Respiratory Syndrome", "DISEASE", 197, 223], ["yellow fever", "ORGANISM", 31, 43], ["Marburg virus", "ORGANISM", 49, 62], ["Ebola virus", "ORGANISM", 90, 101], ["hepatitis C", "ORGANISM", 117, 128], ["HIV", "ORGANISM", 130, 133], ["West Nile virus", "ORGANISM", 170, 185], ["Marburg virus", "SPECIES", 49, 62], ["Ebola virus", "SPECIES", 90, 101], ["HIV", "SPECIES", 130, 133], ["West Nile virus", "SPECIES", 170, 185], ["Marburg virus", "SPECIES", 49, 62], ["Ebola virus", "SPECIES", 90, 101], ["West Nile virus", "SPECIES", 170, 185], ["Severe Acute Respiratory Syndrome (Drexler, 2002; Garrett, 1994; Heymann and Rodier,1997)", "SPECIES", 190, 279], ["yellow fever", "PROBLEM", 31, 43], ["the Marburg virus", "PROBLEM", 45, 62], ["Legionnaires\u2019disease", "PROBLEM", 64, 84], ["the Ebola virus", "PROBLEM", 86, 101], ["Lyme disease", "PROBLEM", 103, 115], ["hepatitis C", "PROBLEM", 117, 128], ["HIV", "PROBLEM", 130, 133], ["AIDS", "PROBLEM", 134, 138], ["Hantaviruspulmonary syndrome", "PROBLEM", 140, 168], ["West Nile virus", "PROBLEM", 170, 185], ["Severe Acute Respiratory Syndrome", "PROBLEM", 190, 223], ["yellow fever", "OBSERVATION", 31, 43], ["Ebola virus", "OBSERVATION", 90, 101], ["Lyme disease", "OBSERVATION", 103, 115], ["Severe", "OBSERVATION_MODIFIER", 190, 196], ["Acute", "OBSERVATION_MODIFIER", 197, 202], ["Respiratory Syndrome", "OBSERVATION", 203, 223]]], ["On the other hand, re-emerging diseases, or those thought tohave been eradicated through aggressive antibiotic vaccination campaigns, havealso begun to reappear with greater frequency in the population in recent years(for example, tuberculosis).Landscape political ecologies of health and diseaseSpatialised political ecology of health approaches \u2013 paying specific heed tointeractions between urban, suburban and rural landscapes \u2013 are important for theirfocus on the interaction between political interests, social institutions and thehuman\u2013non-human environment, which can bring about a greater systemic understandingof health and disease (see Connolly et al., 2017; Jackson and Neely, 2015; King, 2010).", [["tuberculosis", "DISEASE", 231, 243], ["human", "ORGANISM", 546, 551], ["human", "SPECIES", 546, 551], ["human", "SPECIES", 546, 551], ["re-emerging diseases", "PROBLEM", 19, 39], ["aggressive antibiotic vaccination campaigns", "TREATMENT", 89, 132], ["tuberculosis", "PROBLEM", 231, 243], ["diseases", "OBSERVATION", 31, 39], ["tuberculosis", "OBSERVATION", 231, 243]]], ["Given theinterdisciplinary nature of health studies, political ecology is an ideal frameworkthat allows for the use of mixed research methods and incorporates a range ofconceptual approaches (King,2010; Robbins,2012).", [["health studies", "TEST", 37, 51]]], ["This is because of its deep concern for human/environmentrelations, and for its systematic study of the unequal distribution ofsocio-environmental harms and risks.", [["human", "ORGANISM", 40, 45], ["human", "SPECIES", 40, 45], ["human", "SPECIES", 40, 45], ["human/environmentrelations", "PROBLEM", 40, 66], ["its systematic study", "TEST", 76, 96]]], ["More specifically, Connolly (2017) suggests that a landscapepolitical ecology (LPE) perspective can be a useful approach for examining thepolitical ecologies of disease.", [["disease", "PROBLEM", 161, 168], ["disease", "OBSERVATION", 161, 168]]], ["This is because both political ecology and healthgeographies draw on ideas of place and landscape and utilise an understanding ofplace as a socially (re)constructed phenomenon (see King, 2010).Landscape political ecologies of health and diseaseThe concept of landscape is useful for studying processes of extended urbanisation,given the hybrid nature of the term, which allows for blurring distinctions betweenthe urban and rural.", [["disease", "PROBLEM", 237, 244]]], ["This is one way in which sub/urban political ecologies havemoved beyond critiques of \u2018methodological cityism\u2019, by exploring socio-ecologicalprocesses on the urban periphery (c.f.", [["cityism\u2019", "DISEASE", 101, 109]]], ["Thelandscape lens is also important to understand how spatial factors and the physicalordering of the urban environment can directly influence the incidence of diseaseoutbreaks and possible responses to them (Lambin et al., 2010).", [["diseaseoutbreaks", "DISEASE", 160, 176], ["Thelandscape lens", "TREATMENT", 0, 17], ["diseaseoutbreaks", "PROBLEM", 160, 176]]], ["Moreover, Kearns and Moon (2002: 611)have argued that landscape serves as a metaphor for \u2018the complex layerings ofhistory, social structure and built environment that converge in particular places\u2019.This can be seen in the infrastructural (dis)connections and changing nature\u2013societyinteractions that are associated with urban expansion.", [["the infrastructural (dis)connections", "PROBLEM", 218, 254], ["changing nature\u2013societyinteractions", "PROBLEM", 259, 294]]], ["As such, we posit thatparticular landscapes themselves can be structured in such a way that they influencethe likelihood of disease transmission.Landscape political ecologies of health and diseaseSome scholars working on the political ecology of health and disease have usedlandscape as an analytical lens to consider how various health discourses can becomematerialised in particular places (Mulligan et al., 2012; Parizeau, 2015).", [["disease transmission", "PROBLEM", 124, 144], ["disease", "OBSERVATION", 124, 131]]], ["In this way, disease is not only determined through biophysical factors butalso constructed out of a particular set of social and spatial relations which aremediated through the landscape.", [["biophysical factors", "PROTEIN", 52, 71], ["disease", "PROBLEM", 13, 20], ["disease", "OBSERVATION", 13, 20], ["not only", "UNCERTAINTY", 24, 32]]], ["As we will discuss later in the paper, processes ofextended urbanisation can increase risk from infectious diseases \u2013 which arethemselves rapidly evolving \u2013 as the nature and mode of transmission are oftenneither well understood by science nor properly regulated by government,particularly in informal peri-urban settlements common in the developing world.Lambin et al. (2010)have examined specifically how landscape attributes and land use change can have asignificant impact on re-emerging infectious diseases and/or zoonoses.Landscape political ecologies of health and diseaseOthers have used a landscape lens to examine the interconnections between social andenvironmental systems (Fairheadand Leach, 1996; Walker and Fortmann, 2003).", [["infectious diseases", "DISEASE", 96, 115], ["arethemselves", "DISEASE", 124, 137], ["infectious diseases", "DISEASE", 492, 511], ["zoonoses", "DISEASE", 519, 527], ["infectious diseases", "PROBLEM", 96, 115], ["re-emerging infectious diseases", "PROBLEM", 480, 511], ["a landscape lens", "TREATMENT", 596, 612], ["infectious", "OBSERVATION", 96, 106]]], ["In this regard, Wald (2008: 2) has observed howinteractions between microbes, bodies and spaces have the tendency to blend togetheras they \u2018animate the landscape and motivate the plot of the outbreak narrative\u2019.Such analyses draw upon a wide body of literature in science and technology studies(STS) and are influenced by assemblage theory exploring the agency of non-humans inshaping urban environments and the regulation of public space (see Braun, 2008; Jackson and Neely, 2015;Rose, 2007).", [["bodies", "ANATOMY", 78, 84], ["howinteractions between microbes, bodies and spaces", "PROBLEM", 44, 95], ["Such analyses", "TEST", 211, 224], ["technology studies", "TEST", 276, 294]]], ["Urbanpolitical ecology has also mobilised insights from STS to analyse the role ofnon-humans in shaping human health (see Jackson and Neely, 2015).", [["humans", "ORGANISM", 86, 92], ["human", "ORGANISM", 104, 109], ["humans", "SPECIES", 86, 92], ["human", "SPECIES", 104, 109], ["humans", "SPECIES", 86, 92], ["human", "SPECIES", 104, 109]]], ["This has beenachieved through the use of analytical and heuristic concepts such as Haraway\u2019s\u2018cyborgs\u2019 (Haraway, 1991)and Latour\u2019s \u2018quasi-objects\u2019 (Latour, 1993) \u2013 terms that are now commonplace in the literature onurban political ecology and in the social sciences more broadly.Landscape political ecologies of health and diseaseBraun (2008), for example,has argued that infectious diseases emerge from human\u2013non-human relationships,circulation and exchange at a variety of scales from the molecular to the global.This has caused various non-human animals including rodents to enter humansettlements, which is partly to blame for the first Ebola case in Guinea.", [["infectious diseases", "DISEASE", 371, 390], ["Ebola", "DISEASE", 640, 645], ["human", "ORGANISM", 413, 418], ["Ebola", "ORGANISM", 640, 645], ["human", "SPECIES", 413, 418], ["human", "SPECIES", 413, 418], ["infectious diseases", "PROBLEM", 371, 390], ["infectious", "OBSERVATION", 371, 381]]], ["Processesof extended urbanisation have also facilitated the expansion of human settlementsinto former rainforest areas, exposing humans to new possible sources of disease(see Yong, 2018).Deforestation and human encroachment on wildlife habitats have increasedinteractions between wildlife, human beings and livestock, thus heightening thepotential for pathogens to cross the species barrier (Coker et al., 2011).", [["Deforestation", "DISEASE", 187, 200], ["human", "ORGANISM", 73, 78], ["humans", "ORGANISM", 129, 135], ["human", "ORGANISM", 205, 210], ["human", "ORGANISM", 290, 295], ["human", "SPECIES", 73, 78], ["humans", "SPECIES", 129, 135], ["human", "SPECIES", 205, 210], ["human", "SPECIES", 290, 295], ["human", "SPECIES", 73, 78], ["humans", "SPECIES", 129, 135], ["human", "SPECIES", 205, 210], ["human", "SPECIES", 290, 295], ["disease", "PROBLEM", 163, 170], ["Deforestation", "TREATMENT", 187, 200], ["pathogens", "PROBLEM", 352, 361], ["expansion", "OBSERVATION_MODIFIER", 60, 69], ["rainforest areas", "OBSERVATION", 102, 118], ["disease", "OBSERVATION", 163, 170], ["encroachment", "OBSERVATION_MODIFIER", 211, 223]]], ["As Yong (2018: n.p.) hasexplained, such patterns have now become the general context for the spread ofinfectious disease resulting from zoonotic infection, noting that: \u2018wherever peoplepush into wildlife-rich habitats, the potential for such spillover is high\u2019 (Yong, 2018).", [["zoonotic infection", "DISEASE", 136, 154], ["peoplepush", "CHEMICAL", 179, 189], ["the spread ofinfectious disease", "PROBLEM", 89, 120], ["zoonotic infection", "PROBLEM", 136, 154], ["such spillover", "PROBLEM", 237, 251], ["zoonotic", "OBSERVATION_MODIFIER", 136, 144], ["infection", "OBSERVATION", 145, 154]]], ["Suchprocesses have been facilitated by the greater and more rapid movement of people,exposing human populations to a host of microbes, insects and other non-humanorganisms which were previously largely undisturbed by urbanisation.Landscape political ecologies of health and diseaseMaria Kaika\u2019s (2005) cityof flows analogy, born out of the urban political ecology (UPE) literature, is alsouseful for conceptualising the relationship between extended forms of urbanisationand disease.", [["urbanisationand disease", "DISEASE", 459, 482], ["people", "ORGANISM", 78, 84], ["human", "ORGANISM", 94, 99], ["people", "SPECIES", 78, 84], ["human", "SPECIES", 94, 99], ["human", "SPECIES", 94, 99], ["other non-humanorganisms", "PROBLEM", 147, 171], ["urbanisationand disease", "PROBLEM", 459, 482], ["greater", "OBSERVATION_MODIFIER", 43, 50], ["rapid", "OBSERVATION_MODIFIER", 60, 65], ["movement", "OBSERVATION_MODIFIER", 66, 74]]], ["Moreover, \u2018theparticular sociopolitical contexts and spatial configuration of urban regions havestrong implications for how these various non-human natures are urbanised\u2019 (Connolly, 2019).", [["non-human", "ORGANISM", 138, 147], ["spatial configuration", "OBSERVATION", 53, 74]]], ["For thesereasons, landscape political ecology becomes an extremely useful tool forunderstanding the political, social, economic and cultural relationships betweenurban environments and public health.Dynamics of population change ::: Extended urbanisation and infectious disease: Three dimensions", [["infectious disease", "DISEASE", 259, 277], ["infectious", "OBSERVATION", 259, 269], ["dimensions", "OBSERVATION_MODIFIER", 285, 295]]]], "0a8b032ceb0460d9d4c2cc4dc49998730bd96d96": [["Auteurs : Barry Ibrahima Sory 1& (issobarry@yahoo.fr), Bald\u00e9 El Hadj Yaya 1 (yaya_balde@yahoo.fr), B\u00e9avogui Mariam 1 (beavoguimariama7@gmail.com), Camara Abdoulaye 1 (mariboudou@gmail.com), Samoura Aly 1 (samouraaly01@gmail.com), Ko\u00efvogui Kokoulo 1 (koklokoivogui@gmail.com) , Ko\u00efvogui Diarra 1 (koivoguidiara@gmail.com), Soumaoro Morlaye 1 (soumed555@gmail.com), Sow Aminata 1 (rabiatoudioulde121@gmail.com), Kourouma Moussa 1 (doumbouyamoussa2550@gmail.com), Bah Mamadou Bassirou 1 (bachirov80@yahoo.fr), Bald\u00e9 Mamadou Aliou 1 (baldealiou800@gmail.com) , Sylla Ibrahima Sory 1 (ibsosyl@yahoo.fr), Kon\u00e9 Alpha 1 (alafekone@gmail.com), Diakit\u00e9 Souleymane 1 La nouvelle pand\u00e9mie de coronavirus (COVID-19) est la principale crise sanitaire mondiale de notre \u00e9poque et la plus grande menace \u00e0 laquelle nous avons \u00e9t\u00e9 confront\u00e9s au cours de ce si\u00e8cle.", [["coronavirus", "SPECIES", 680, 691], ["Bald\u00e9", "TEST", 55, 60], ["B\u00e9avogui Mariam", "TREATMENT", 99, 114], ["Camara Abdoulaye", "TREATMENT", 147, 163], ["Samoura Aly", "TREATMENT", 190, 201], ["Ko\u00efvogui Kokoulo", "TREATMENT", 230, 246], ["Ko\u00efvogui Diarra", "TREATMENT", 277, 292], ["Soumaoro Morlaye", "TREATMENT", 322, 338], ["Sow Aminata", "TREATMENT", 364, 375], ["Kourouma Moussa", "TREATMENT", 410, 425], ["Bah Mamadou Bassirou", "TREATMENT", 461, 481], ["Bald\u00e9 Mamadou Aliou", "TREATMENT", 507, 526], ["Sylla Ibrahima Sory", "TREATMENT", 557, 576], ["Kon\u00e9 Alpha", "TREATMENT", 599, 609], ["Diakit\u00e9 Souleymane", "TREATMENT", 635, 653], ["COVID", "TEST", 693, 698], ["est la principale", "TREATMENT", 703, 720]]], ["Selon l'agence nationale de la s\u00e9curit\u00e9 sanitaire (ANSS) qui est l'organe national charg\u00e9 de la gestion des \u00e9pid\u00e9mies et des pand\u00e9mies, 1927 cas de COVID 19 ont \u00e9t\u00e9 confirm\u00e9s, 11 dec\u00e8s avec plus de 4000 sujets contacts.", [["qui est l'organe national charg\u00e9 de la gestion des", "TREATMENT", 57, 107]]], ["L'\u00e9tude a consist\u00e9 \u00e0 \u00e9valuer l'impact de la pand\u00e9mie sur l'utilisation du service par les patients durant les premi\u00e8res semaines de la pand\u00e9mie.", [["patients", "ORGANISM", 90, 98], ["patients", "SPECIES", 90, 98]]], ["Durant cette \u00e9tude allant de Mars \u00e0 Avril 2020,nous avons recens\u00e9 130 patients en consultation contre 450 patients pour les deux mois pr\u00e9c\u00e9dant la d\u00e9claration officielle de la pand\u00e9mie en Guin\u00e9e soit une baisse de 71,1% (320 patients).", [["patients", "ORGANISM", 70, 78], ["patients", "ORGANISM", 106, 114], ["patients", "ORGANISM", 225, 233], ["patients", "SPECIES", 70, 78], ["patients", "SPECIES", 106, 114], ["patients", "SPECIES", 225, 233]]], ["La m\u00eame remarque a \u00e9t\u00e9 faite en hospitalisation avec une baisse de 75% (35 patients contre 140 pour les deux mois pr\u00e9c\u00e9dents la pand\u00e9mie).", [["patients", "ORGANISM", 75, 83], ["patients", "SPECIES", 75, 83]]]], "544658fdbf9561c92001e4f7ed43b7ebf776282f": [["By far the most abundant species in nature is the virus that cannot replicate by itself.", [["the virus", "PROBLEM", 46, 55], ["most abundant", "OBSERVATION_MODIFIER", 11, 24], ["species", "OBSERVATION", 25, 32], ["virus", "OBSERVATION", 50, 55]]], ["Viruses, parasitic entities, are found in virtually all unicellular and multicellular creatures.", [["Viruses", "PROBLEM", 0, 7], ["parasitic entities", "PROBLEM", 9, 27], ["parasitic entities", "OBSERVATION", 9, 27], ["unicellular", "OBSERVATION_MODIFIER", 56, 67], ["multicellular creatures", "OBSERVATION", 72, 95]]], ["Viruses are everywhere.", [["Viruses", "PROBLEM", 0, 7]]], ["While smallest in size among all species, they can ingeniously replicate, persist, and survive in their individual hosts and/or host populations, and are transmittable among hosts.", [["smallest", "OBSERVATION_MODIFIER", 6, 14], ["size", "OBSERVATION_MODIFIER", 18, 22], ["all species", "OBSERVATION_MODIFIER", 29, 40]]], ["Viruses are sometimes inflicting or fatal for host species and are sometimes inter-species replicons.", [["Viruses", "PROBLEM", 0, 7], ["host species", "PROBLEM", 46, 58], ["host species", "OBSERVATION", 46, 58]]], ["Unseen viruses thus can reshuffle the whole world through accumulations of their subtle biological effects.", [["Unseen viruses", "PROBLEM", 0, 14], ["viruses", "OBSERVATION", 7, 14], ["subtle", "OBSERVATION_MODIFIER", 81, 87], ["biological effects", "OBSERVATION", 88, 106]]], ["In other words, viruses can shape the entire environment around us and are able to directly and/or indirectly influence us by their biologic activities.", [["viruses", "OBSERVATION", 16, 23]]], ["Virology is a multidisciplinary research field and, as an academic discipline of the biology, it extensively analyzes all aspects of viruses derived from every living species by scientific systems/methodologies currently available to us as exemplified and fully described in a series of Frontiers special issues designated \"Research Topic\" (RT) in the Virology section of Frontiers in Microbiology Adachi, 2010, 2017; Miyazaki et al., 2012; Nomaguchi et al., 2012; Berkhout and Coombs, 2013; Sato et al., 2013; Adachi and Miura, 2014; Dutilh et al., 2017; Sanfa\u00e7on, 2017; Yamamoto et al., 2017) .", [["viruses", "PROBLEM", 133, 140], ["Coombs", "TEST", 478, 484], ["Adachi", "TEST", 511, 517]]], ["I wish to emphasize here again that virology is a branch of biological sciences studying the fundamental attributes of a wide variety of unique characteristic viruses.", [["unique characteristic viruses", "PROBLEM", 137, 166], ["viruses", "OBSERVATION", 159, 166]]]], "8854ec775bfafa31c18c01aad8dfb8dbeabfd4f1": [["To the Editor-As of April 1, the total number of SARS-Cov-2-positive cases in Vietnam reached 218, and 37 of these were infected within a public hospital in Hanoi, the capital of Vietnam.", [["SARS", "DISEASE", 49, 53], ["Cov-2", "GENE_OR_GENE_PRODUCT", 54, 59], ["SARS", "TEST", 49, 53], ["infected", "OBSERVATION", 120, 128]]], ["1 Thus far, this hospital is the largest COVID-19 hotspot in the country.", [["COVID-19 hotspot", "DNA", 41, 57]]]], "PMC1876810": [["IntroductionThe 2001 FMD epidemic in the UK had a substantial cost in human, animal health and economic terms (Alexandersen et al. [1], Kao [2]).", [["human", "ORGANISM", 70, 75], ["human", "SPECIES", 70, 75], ["human", "SPECIES", 70, 75]]], ["Understanding the risk factors underlying the transmission dynamics of that epidemic and evaluating the effectiveness of the control measures are essential to minimise the scale and cost of any future outbreak.", [["the risk factors", "PROBLEM", 14, 30], ["the control measures", "TREATMENT", 121, 141]]], ["Epidemic modelling [3], [4], [5]\u2013[7] proved critical to decision making about control policies which were (in some cases controversially) adopted to control the 2001 epidemic [8]\u2013[10].", [["[4]", "SIMPLE_CHEMICAL", 24, 27], ["[5]\u2013[7]", "SIMPLE_CHEMICAL", 29, 36], ["Epidemic modelling", "PROBLEM", 0, 18]]], ["Modelling now has a \u2018peace-time\u2019 contingency planning role.IntroductionOne weakness of the modelling studies undertaken in 2001 was the relatively ad-hoc nature of the parameter estimation methods employed.", [["One weakness", "PROBLEM", 71, 83], ["the modelling studies", "TEST", 87, 108], ["weakness", "OBSERVATION", 75, 83]]], ["In their first paper, Ferguson et al. [4] used maximum likelihood methods to fit to the observed incidence time series, but did not attempt to fit to the spatio-temporal pattern of spread.", [["temporal", "ANATOMY_MODIFIER", 161, 169], ["spread", "OBSERVATION", 181, 187]]], ["In their later work, the same authors developed a more robust method for estimating species-specific susceptibility and infectiousness parameters and spatial kernel parameters (see Supplementary Information to [3]), but at the time the statistical basis for the methods developed was lacking.", [["estimating species", "PROBLEM", 73, 91], ["infectiousness parameters", "TEST", 120, 145], ["spatial kernel parameters", "TEST", 150, 175], ["the methods", "TREATMENT", 258, 269]]], ["In retrospect, the methods developed turned out to be closely related to those developed during the SARS epidemic by Wallinga and Teunis [11], although the earlier work incorporated population denominator data to allow for spatial- and species-based heterogeneity in disease transmission.", [["SARS", "DISEASE", 100, 104], ["the methods", "TEST", 15, 26], ["based heterogeneity in disease transmission", "PROBLEM", 244, 287], ["heterogeneity", "OBSERVATION_MODIFIER", 250, 263], ["disease", "OBSERVATION", 267, 274]]], ["Keeling et al. [5] used maximum likelihood methods to estimate transmission parameters, but it was also supplemented by more ad hoc least-squares matching to regional incidence time series.IntroductionTherefore there remains a need to develop rigorous modern statistical approaches for parameter estimation of non-linear models for the 2001 FMD outbreak.", [["FMD", "DISEASE", 341, 344], ["FMD", "SPECIES", 341, 344], ["parameter estimation", "TEST", 286, 306]]], ["Bayesian Markov Chain Monte Carlo (MCMC) techniques are the best established such methods and have been successfully employed in the analysis of a range of spatiotemporal outbreak data in the past [12]\u2013[14], as well as to purely temporal incidence data [15], [16].", [["Bayesian Markov Chain Monte Carlo (MCMC) techniques", "TREATMENT", 0, 51]]], ["Here we develop MCMC-based inference models for the 2001 FMD epidemic in GB.", [["FMD", "DISEASE", 57, 60], ["MCMC", "PROBLEM", 16, 20], ["GB", "ANATOMY", 73, 75]]], ["The models examine: the extent to which transmission was spatially localised and the temporal variation in transmission, species-specific variation in susceptibility, infectiousness and heterogeneity in contact rates between and within species.Data ::: MethodsWe take the farm as the unit of our study and ignore the possible impact of within-farm epidemic dynamics.", [["the temporal variation in transmission", "PROBLEM", 81, 119], ["susceptibility", "PROBLEM", 151, 165], ["infectiousness", "PROBLEM", 167, 181], ["heterogeneity in contact rates", "PROBLEM", 186, 216], ["Methods", "TREATMENT", 253, 260], ["our study", "TEST", 292, 301], ["temporal", "OBSERVATION_MODIFIER", 85, 93], ["variation", "OBSERVATION_MODIFIER", 94, 103]]], ["Thus we implicitly assume disease spread within a farm is so rapid as to be practically instantaneous, with all animals on a farm becoming infectious at the same time.Data ::: MethodsOur data consists of information on all the farms in the UK listed in the 2000 agricultural census [see http://www.defra.gov.uk/footandmouth/cases/index.htm ].", [["disease spread", "PROBLEM", 26, 40], ["infectious", "PROBLEM", 139, 149], ["disease", "OBSERVATION", 26, 33], ["infectious", "OBSERVATION", 139, 149]]], ["A partition of all GB farms according to the animal types represented is shown in Figure 1a.", [["A partition of all GB farms", "PROBLEM", 0, 27], ["GB farms", "OBSERVATION", 19, 27]]], ["Their geographical distribution is represented in Figure 1b as the number of farms per 5\u00d75 km.", [["geographical", "OBSERVATION_MODIFIER", 6, 18], ["distribution", "OBSERVATION_MODIFIER", 19, 31]]], ["Notice the high density areas in the North West (Cumbria), South West (Devon), Wales and Scotland where the main epidemic foci developed.", [["the high density areas", "PROBLEM", 7, 29], ["high", "OBSERVATION_MODIFIER", 11, 15], ["density", "OBSERVATION", 16, 23], ["North", "ANATOMY_MODIFIER", 37, 42], ["main", "OBSERVATION_MODIFIER", 108, 112], ["epidemic", "OBSERVATION_MODIFIER", 113, 121], ["foci", "OBSERVATION", 122, 126]]], ["There is also an area of high density in the Shetland Islands corresponding to very small crofter smallholdings.", [["high density in the Shetland Islands", "PROBLEM", 25, 61], ["very small crofter smallholdings", "PROBLEM", 79, 111], ["area", "OBSERVATION_MODIFIER", 17, 21], ["high", "OBSERVATION_MODIFIER", 25, 29], ["density", "OBSERVATION", 30, 37], ["Shetland Islands", "OBSERVATION", 45, 61], ["very", "OBSERVATION_MODIFIER", 79, 83], ["small", "OBSERVATION_MODIFIER", 84, 89], ["crofter", "OBSERVATION_MODIFIER", 90, 97], ["smallholdings", "OBSERVATION", 98, 111]]], ["Figure 1c and d show the numbers of sheep and cattle kept per 5\u00d75 km square.Data ::: MethodsDuring the 2001 FMD outbreak, a total of 2026 infected premises (IPs) were recorded \u2013 farms where FMD was diagnosed, and which were subsequently culled.", [["sheep", "ORGANISM", 36, 41], ["sheep", "SPECIES", 36, 41], ["cattle", "SPECIES", 46, 52], ["sheep", "SPECIES", 36, 41], ["cattle", "SPECIES", 46, 52], ["FMD", "SPECIES", 190, 193]]], ["The IP dataset contains, for each farm, the estimated date of infection (determined by a clinical evaluation of the age of lesions on affected animals), and the dates of disease reporting, confirmation and culling.Data ::: MethodsA total of 7457 other (non-IP) farms were also culled \u2013 mostly as contiguous premises (CPs, about 3103) or dangerous contacts (DCs, about 1287), but some under other local culling policies used in Cumbria and Scotland.", [["lesions", "ANATOMY", 123, 130], ["DCs", "ANATOMY", 357, 360], ["infection", "DISEASE", 62, 71], ["lesions", "PATHOLOGICAL_FORMATION", 123, 130], ["DCs", "CELL", 357, 360], ["DCs", "CELL_TYPE", 357, 360], ["infection", "PROBLEM", 62, 71], ["a clinical evaluation", "TEST", 87, 108], ["lesions", "PROBLEM", 123, 130], ["disease", "PROBLEM", 170, 177], ["infection", "OBSERVATION", 62, 71], ["lesions", "OBSERVATION", 123, 130]]], ["For instance about 1846 (79%) out of a total of 2342 sheep farms in Cumbria had all sheep culled under the \u201clocal 3 km radial sheep cull\u201d policy adopted there.", [["sheep", "ORGANISM", 53, 58], ["sheep", "ORGANISM", 84, 89], ["sheep", "SPECIES", 53, 58], ["sheep", "SPECIES", 84, 89], ["sheep", "SPECIES", 126, 131], ["sheep", "SPECIES", 53, 58], ["sheep", "SPECIES", 84, 89], ["sheep", "SPECIES", 126, 131]]], ["Some of the farms (about 30) were recorded both as DCs and CPs.", [["DCs", "ANATOMY", 51, 54], ["DCs", "CELL", 51, 54], ["DCs", "CELL_TYPE", 51, 54]]], ["Multiple records per farm were often found in the disease control management system dataset, and it was often unclear whether this was due to data entry errors or as a result of sequential species-specific culls on the same farm.", [["the disease control management system dataset", "PROBLEM", 46, 91], ["data entry errors", "PROBLEM", 142, 159], ["sequential species", "PROBLEM", 178, 196]]], ["In our analysis we therefore considered the whole farm to be culled at the last recorded date of culling.Data ::: MethodsThe most frequent species are cattle and sheep (see Figure 1a).", [["cattle", "ORGANISM", 151, 157], ["sheep", "ORGANISM_SUBDIVISION", 162, 167], ["cattle", "SPECIES", 151, 157], ["sheep", "SPECIES", 162, 167], ["cattle", "SPECIES", 151, 157], ["sheep", "SPECIES", 162, 167], ["our analysis", "TEST", 3, 15], ["Methods", "TREATMENT", 114, 121], ["most frequent", "OBSERVATION_MODIFIER", 125, 138], ["species", "OBSERVATION", 139, 146]]], ["There are less than 3% farms with pigs only and only 10 farms with just pigs were diagnosed as IPs in 2001 (less than 1% of all the IPs).", [["pigs", "ORGANISM", 34, 38], ["pigs", "ORGANISM", 72, 76], ["pigs", "SPECIES", 34, 38], ["pigs", "SPECIES", 72, 76], ["pigs", "SPECIES", 34, 38], ["pigs", "SPECIES", 72, 76], ["IPs", "TEST", 95, 98], ["less", "OBSERVATION_MODIFIER", 10, 14]]], ["This indicates a-priori that pigs contributed far less to the 2001 outbreak than many other FMD outbreaks (despite their high levels of shedding [1], [17]), and we therefore decided to discard pigs-only farms from the current study to simplify the analysis.", [["FMD", "DISEASE", 92, 95], ["pigs", "ORGANISM", 29, 33], ["pigs", "ORGANISM", 193, 197], ["pigs", "SPECIES", 29, 33], ["pigs", "SPECIES", 193, 197], ["pigs", "SPECIES", 29, 33], ["FMD", "SPECIES", 92, 95], ["many other FMD outbreaks", "PROBLEM", 81, 105], ["the current study", "TEST", 214, 231], ["the analysis", "TEST", 244, 256]]], ["The Sensitivity Analysis section shows that this simplification does not significantly affect estimates of other epidemiological parameters.", [["The Sensitivity Analysis section", "TEST", 0, 32]]], ["Each farm i at the location (xi, yi) is associated with an infection time ti (if infected), a removal time ri (if slaughtered) and two integers and representing, respectively, the number of cattle and sheep on the farm.", [["infection", "DISEASE", 59, 68], ["cattle", "ORGANISM", 190, 196], ["sheep", "ORGANISM", 201, 206], ["cattle", "SPECIES", 190, 196], ["sheep", "SPECIES", 201, 206], ["cattle", "SPECIES", 190, 196], ["sheep", "SPECIES", 201, 206], ["a removal time ri", "TREATMENT", 92, 109], ["infection", "OBSERVATION", 59, 68]]], ["Sc and Ss represent per-capita cattle and sheep susceptibility, respectively, while Ic and Is represent per capita cattle and sheep infectivity.", [["Sc", "GENE_OR_GENE_PRODUCT", 0, 2], ["cattle", "ORGANISM", 31, 37], ["sheep", "ORGANISM", 42, 47], ["cattle", "ORGANISM", 115, 121], ["sheep", "ORGANISM", 126, 131], ["cattle", "SPECIES", 31, 37], ["sheep", "SPECIES", 42, 47], ["cattle", "SPECIES", 115, 121], ["sheep", "SPECIES", 126, 131], ["cattle", "SPECIES", 31, 37], ["sheep", "SPECIES", 42, 47], ["cattle", "SPECIES", 115, 121], ["sheep", "SPECIES", 126, 131], ["per-capita cattle", "OBSERVATION", 20, 37], ["sheep susceptibility", "OBSERVATION", 42, 62], ["sheep infectivity", "OBSERVATION", 126, 143]]], ["The susceptibility is a relative measure of animal sensitivity to the disease whereas infectivity represents the infectious risk posed by an animal to others.", [["the disease whereas infectivity", "PROBLEM", 66, 97], ["disease", "OBSERVATION", 70, 77], ["infectious", "OBSERVATION_MODIFIER", 113, 123]]], ["We use a continuous kernel to describe how the probability of contact between farms scaled with distance.", [["a continuous kernel", "TREATMENT", 7, 26]]], ["Transmission is naturally assumed to decrease with the distance between farms according to the power law(1)where dij represents the Euclidian distance between the infected farm i and the susceptible farm j.", [["decrease", "OBSERVATION_MODIFIER", 37, 45], ["infected", "OBSERVATION", 163, 171]]], ["The parameters a (kernel offset) and \u03b3 (kernel power) are to be estimated.", [["a (kernel offset)", "TREATMENT", 15, 32], ["\u03b3 (kernel power", "TREATMENT", 37, 52]]], ["The kernel captures all forms of movement and contact between farms and as such, the use of a simple 2 parameter function is inevitably a highly simplified representation of the true complexity of inter-farm contacts.", [["a simple 2 parameter function", "TEST", 92, 121], ["inter-farm contacts", "PROBLEM", 197, 216]]], ["We examined other functional forms for the kernel (such as those used in some other analyses [19]) but the resulting model fits were much poorer than found using the power-law kernel above.Model formulation ::: MethodsGiven the susceptibility and infectiousness parameters and the kernel, the infection hazard from an infected farm j to a susceptible farm i is then quantified by(2)This model is over-specified as stated, so we arbitrarily assume Ss = 1 throughout, meaning Sc represents the ratio of cattle-to-sheep susceptibility.", [["infection", "DISEASE", 293, 302], ["cattle", "ORGANISM", 501, 507], ["sheep", "ORGANISM", 511, 516], ["cattle", "SPECIES", 501, 507], ["sheep", "SPECIES", 511, 516], ["cattle", "SPECIES", 501, 507], ["sheep", "SPECIES", 511, 516], ["infectiousness parameters", "TEST", 247, 272], ["the infection hazard", "PROBLEM", 289, 309], ["infection", "OBSERVATION", 293, 302], ["infected", "OBSERVATION_MODIFIER", 318, 326], ["farm j", "OBSERVATION", 327, 333]]], ["For a constant (distance-independent) kernel this is just a mass-action closed epidemic model with heterogeneous susceptibility and infectiousness.", [["a constant (distance-independent) kernel", "TREATMENT", 4, 44], ["a mass", "PROBLEM", 58, 64], ["heterogeneous susceptibility", "PROBLEM", 99, 127], ["infectiousness", "PROBLEM", 132, 146], ["mass", "OBSERVATION", 60, 64], ["heterogeneous", "OBSERVATION_MODIFIER", 99, 112], ["susceptibility", "OBSERVATION", 113, 127]]], ["This model assumes susceptibility and infectiousness parameters scale linearly with the number of animals of different species on the farm, a relatively strong assumption imposed for model parsimony reasons.", [["infectiousness parameters scale", "PROBLEM", 38, 69], ["susceptibility", "OBSERVATION_MODIFIER", 19, 33], ["infectiousness", "OBSERVATION", 38, 52], ["different", "OBSERVATION_MODIFIER", 109, 118], ["species", "OBSERVATION_MODIFIER", 119, 126]]], ["The mixing matrix embedded in (2) quantifies the 4 species-specific mixing rates between animals on different farms: cattle-to-cattle (ScIc) sheep-to-cattle (ScIs), cattle-to-sheep (SsIc) and sheep-to-sheep (SsIs).", [["cattle", "ORGANISM", 127, 133], ["sheep", "ORGANISM", 141, 146], ["cattle", "ORGANISM", 150, 156], ["sheep", "ORGANISM", 175, 180], ["sheep", "ORGANISM", 192, 197], ["sheep", "ORGANISM", 201, 206], ["cattle", "SPECIES", 117, 123], ["cattle", "SPECIES", 127, 133], ["sheep", "SPECIES", 141, 146], ["cattle", "SPECIES", 150, 156], ["cattle", "SPECIES", 165, 171], ["sheep", "SPECIES", 175, 180], ["sheep", "SPECIES", 192, 197], ["sheep", "SPECIES", 201, 206], ["cattle", "SPECIES", 117, 123], ["cattle", "SPECIES", 127, 133], ["sheep", "SPECIES", 141, 146], ["cattle", "SPECIES", 150, 156], ["cattle", "SPECIES", 165, 171], ["sheep", "SPECIES", 175, 180], ["sheep", "SPECIES", 192, 197], ["sheep", "SPECIES", 201, 206], ["The mixing matrix", "TREATMENT", 0, 17], ["the 4 species", "PROBLEM", 45, 58], ["cattle", "TEST", 165, 171], ["mixing matrix", "OBSERVATION", 4, 17]]], ["This model formulation is identical to that used by Keeling et al. [5], except for the functional form of kernel used.Model formulation ::: MethodsThe force of infection on a susceptible farm i at time t depends on the whole history of events and is just(3)where(4)By default, we assume a latent period of 1 day (latency is represented within the function L); i.e. farms are infectious the day after they are infected.", [["infection", "DISEASE", 160, 169], ["This model formulation", "TREATMENT", 0, 22], ["Methods", "TREATMENT", 140, 147], ["infection", "PROBLEM", 160, 169], ["infected", "PROBLEM", 409, 417], ["infection", "OBSERVATION", 160, 169], ["infectious", "OBSERVATION", 375, 385], ["infected", "OBSERVATION", 409, 417]]], ["However, we test the sensitivity of our estimates to the assumption by also examining latent periods of 2 and 3 days.Model formulation ::: MethodsThe probability density function that farm i is infected at time t is then given byHence, the contribution that a farm i, observed to be infected at time t, makes to the log likelihood is just:(5)A farm which is not infected contributes to the overall likelihood the probability that it escapes infection during the observation period, i.e. until the time it is culled (ri) or for the duration of the epidemic T, whichever is shorter.", [["infection", "DISEASE", 441, 450], ["Methods", "TREATMENT", 139, 146], ["escapes infection", "PROBLEM", 433, 450], ["density", "OBSERVATION", 162, 169], ["infected", "OBSERVATION_MODIFIER", 194, 202], ["infected", "OBSERVATION", 283, 291], ["escapes", "OBSERVATION_MODIFIER", 433, 440], ["infection", "OBSERVATION", 441, 450]]], ["Its contribution to the log likelihood is therefore(6)The total log likelihood of the model can be written as(7)We then extend the simple model above by introducing an additional parameter to understand to what extent the transmission within species is altered by between species transmission.", [["log likelihood", "OBSERVATION_MODIFIER", 24, 38]]], ["The force of infection (3) and model log likelihood equation (7) change accordingly.Model formulation ::: MethodsAssuming transmission parameters were constant in time throughout the epidemic is obviously a crude simplification.", [["infection", "DISEASE", 13, 22], ["infection", "PROBLEM", 13, 22], ["MethodsAssuming transmission parameters", "TEST", 106, 145], ["infection", "OBSERVATION", 13, 22]]], ["However, allowing infectivity to vary continuously in time results in an over-specified model and problems of parameter identification and confounding.", [["parameter identification", "TEST", 110, 134]]], ["We therefore examined two sets of models in which changes in transmission parameter were restricted to 2 significant points in time denoted by Tcut, namely 23rd February (when the national ban on animal movements was introduced) and 31st March (when control measures were intensified and the so called 24/48 hour IP/CP culling policy was introduced).", [["transmission parameter", "TEST", 61, 83], ["IP/CP culling policy", "TREATMENT", 313, 333]]], ["Models were respectively fitted to the individual case data from the start of the epidemic (conditioning on the first infection) or from after 23rd February (conditioning on the 54 farms that were already infected by that date).", [["infection", "DISEASE", 118, 127], ["the first infection", "PROBLEM", 108, 127]]], ["A detailed history of the epidemic is given by Kao [9].Model formulation ::: MethodsWe separately fitted model variants which assumed a discrete change in parameters on 23rd February and on 31st March.", [["a discrete change in parameters", "PROBLEM", 134, 165], ["discrete", "OBSERVATION_MODIFIER", 136, 144], ["change", "OBSERVATION", 145, 151]]], ["We fitted four separate time-varying model variants: (i) varying the cattle infectivity by a factor and keeping sheep infectivity constant through time (Cattle Infectivity model); (ii) varying sheep infectivity by a factor but not cattle infectivity (Sheep Infectivity model); (iii) varying both cattle and sheep infectivity by the same ratio (Cattle & Sheep Infectivity model); (iv) varying the kernel parameters (Time Varying Kernel model).", [["cattle", "ORGANISM", 69, 75], ["sheep", "ORGANISM", 193, 198], ["cattle", "ORGANISM", 296, 302], ["sheep", "ORGANISM", 307, 312], ["sheep", "SPECIES", 112, 117], ["sheep", "SPECIES", 193, 198], ["cattle", "SPECIES", 231, 237], ["cattle", "SPECIES", 296, 302], ["sheep", "SPECIES", 307, 312], ["cattle", "SPECIES", 69, 75], ["sheep", "SPECIES", 112, 117], ["sheep", "SPECIES", 193, 198], ["cattle", "SPECIES", 231, 237], ["cattle", "SPECIES", 296, 302], ["sheep", "SPECIES", 307, 312], ["the cattle infectivity", "PROBLEM", 65, 87], ["sheep infectivity", "PROBLEM", 112, 129], ["varying sheep infectivity", "PROBLEM", 185, 210], ["cattle infectivity", "PROBLEM", 231, 249], ["sheep infectivity", "TREATMENT", 307, 324], ["Cattle & Sheep Infectivity model)", "TREATMENT", 344, 377], ["iv) varying the kernel parameters", "TREATMENT", 380, 413]]], ["For the last model variant we also fitted a version which includes non-assortative mixing between species (see equation (8)).", [["a version", "TEST", 42, 51], ["non-assortative mixing between species", "PROBLEM", 67, 105]]], ["When fitting models with time varying infectivity parameters we actually fit Ipost and the ratio \u03bc = Ipre/Ipost we called infectivity factor.", [["Ipre", "PROTEIN", 101, 105], ["Ipost", "PROTEIN", 106, 111], ["infectivity factor", "PROTEIN", 122, 140]]], ["This is a within species ratio, a parameter directly fitted by the models, unlike the between species infectivity ratio additionally calculated as explained later in the text (see Parameter estimates section).Model formulation ::: MethodsNote that all models above treat the epidemic as fully observed, i.e. infection times are assumed to be known (when in fact only estimated infection times are known \u2013 see Sensitivity Analysis section), and only IPs are assumed to be infectious.Statistical inference and model comparison ::: MethodsWe adopt a Bayesian framework for statistical inference and use MCMC methods for fitting the model to individual case data.", [["infection", "DISEASE", 308, 317], ["infection", "DISEASE", 377, 386], ["the between species infectivity ratio", "PROBLEM", 82, 119], ["the epidemic", "PROBLEM", 271, 283], ["infection", "PROBLEM", 308, 317], ["estimated infection", "PROBLEM", 367, 386], ["infectious", "PROBLEM", 471, 481], ["MCMC methods", "TREATMENT", 600, 612], ["infection", "OBSERVATION", 308, 317], ["infection", "OBSERVATION", 377, 386], ["assumed to be", "UNCERTAINTY", 457, 470], ["infectious", "OBSERVATION", 471, 481]]], ["This is not strictly necessary, given our simplifying assumption that the epidemic was completely observed, but it provides a more consistent and robust framework within which to relax that assumption in future work.Statistical inference and model comparison ::: MethodsWe obtained parameter estimates and equal-tailed 95% credible intervals from the marginal posterior distributions of the fitted parameters.", [["the epidemic", "PROBLEM", 70, 82], ["not strictly necessary", "UNCERTAINTY", 8, 30], ["marginal", "OBSERVATION_MODIFIER", 351, 359], ["posterior", "ANATOMY_MODIFIER", 360, 369]]], ["For the basic model for instance we estimated the relative cattle susceptibility, Sc, two infectivity parameters (Ic(t)\u2261Ic and Is(t)\u2261Is for all t) and two kernel parameters (\u03b3(t)\u2261\u03b3post\u2261\u03b3pre\u2261\u03b3 and a(t)\u2261apost\u2261apre\u2261a for all t).Statistical inference and model comparison ::: MethodsWe used the posterior mean deviance as a Bayesian measure of fit or model adequacy as defined by Spiegelhalter et al. [20].", [["cattle", "SPECIES", 59, 65], ["kernel parameters", "TEST", 155, 172], ["\u03b3post\u2261\u03b3pre\u2261\u03b3", "TEST", 179, 191], ["\u2261apost\u2261apre\u2261a", "TEST", 200, 213]]], ["The posterior density deviance is defined as:where log{P(y|\u03b8)} is the log-likelihood function for the observed data vector y given the parameter vector \u03b8 and C is a constant which does not need to be known for model-comparison purposes (being a function of the data alone).", [["The posterior density deviance", "PROBLEM", 0, 30], ["the log", "TEST", 66, 73], ["posterior", "ANATOMY_MODIFIER", 4, 13], ["density", "OBSERVATION", 14, 21]]], ["The smaller the mean posterior deviance, the better the corresponding model fits the data.Statistical inference and model comparison ::: MethodsIf the posterior deviance distributions for two different models overlap significantly, it is necessary to use additional criteria to compare model fit \u2013 namely a comparison of the relative complexity of the models.", [["Methods", "TREATMENT", 137, 144], ["smaller", "OBSERVATION_MODIFIER", 4, 11], ["mean", "OBSERVATION_MODIFIER", 16, 20], ["posterior", "OBSERVATION_MODIFIER", 21, 30], ["deviance", "OBSERVATION", 31, 39], ["posterior", "ANATOMY_MODIFIER", 151, 160], ["deviance", "OBSERVATION", 161, 169]]], ["We define the complexity of a model by its effective number of parameters, pD, defined aswhere E[ ] represents taking expectations (the posterior average).", [["pD", "TREATMENT", 75, 77]]], ["The DIC is then defined as", [["DIC", "DISEASE", 4, 7], ["The DIC", "PROBLEM", 0, 7], ["DIC", "OBSERVATION", 4, 7]]]], "9c01856d38f33cdbe16983efd12b56c4b33e51aa": [["I. INTRODUCTIONThe iris is a part of the eye that controls the pupil's size, regulating the amount of light that enters the eye.", [["iris", "ANATOMY", 19, 23], ["eye", "ANATOMY", 41, 44], ["pupil", "ANATOMY", 63, 68], ["eye", "ANATOMY", 124, 127], ["iris", "ORGAN", 19, 23], ["eye", "ORGAN", 41, 44], ["pupil", "ORGANISM_SUBDIVISION", 63, 68], ["eye", "ORGAN", 124, 127], ["iris", "OBSERVATION", 19, 23], ["eye", "ANATOMY", 41, 44], ["pupil", "OBSERVATION", 63, 68], ["size", "OBSERVATION_MODIFIER", 71, 75], ["amount", "OBSERVATION_MODIFIER", 92, 98], ["eye", "ANATOMY", 124, 127]]], ["It is the part of the eye with coloring based on the amount of melatonin pigment within the muscle.I. INTRODUCTIONThe individual's irises patterns are unique and structurally distinct, which remains stable throughout adult life and makes it suitable to be used for reliable automatic recognition of persons as an attractive goal.", [["eye", "ANATOMY", 22, 25], ["muscle", "ANATOMY", 92, 98], ["melatonin", "CHEMICAL", 63, 72], ["melatonin", "CHEMICAL", 63, 72], ["eye", "ORGAN", 22, 25], ["melatonin", "SIMPLE_CHEMICAL", 63, 72], ["muscle", "ORGAN", 92, 98], ["persons", "ORGANISM", 299, 306], ["persons", "SPECIES", 299, 306], ["eye", "ANATOMY", 22, 25], ["melatonin pigment", "OBSERVATION", 63, 80], ["muscle", "ANATOMY", 92, 98], ["structurally", "OBSERVATION_MODIFIER", 162, 174], ["distinct", "OBSERVATION_MODIFIER", 175, 183], ["stable", "OBSERVATION_MODIFIER", 199, 205]]], ["Iris recognition is employed as the most reliable and accurate biometric identification system, compared with other biometric technologies, such as speech, finger, and face recognition [1] [2] [3] [4] .I. INTRODUCTIONAutomated iris segmentation has been an attractive topic of research in the recent past [5, 6] , and many methods [7] [8] [9] have been proposed to solve the problem.", [["iris", "ANATOMY", 227, 231], ["iris", "MULTI-TISSUE_STRUCTURE", 227, 231], ["[7] [8] [9]", "SIMPLE_CHEMICAL", 331, 342], ["other biometric technologies", "TEST", 110, 138], ["speech, finger, and face recognition", "TEST", 148, 184], ["finger", "ANATOMY", 156, 162]]], ["The first automatic method was presented by Daugman [10] using an efficient integrodifferential operator, which is still utilized in today's most of the iris recognition systems.", [["iris", "ANATOMY", 153, 157], ["an efficient integrodifferential operator", "TREATMENT", 63, 104]]], ["Image processing techniques as the first step can be applied to extract the unique pattern from the image, and encode it [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .", [["[11] [12] [13] [14] [15] [16] [17] [18] [19] [20]", "CHEMICAL", 121, 170], ["[11] [12] [13] [14] [15] [16] [17] [18] [19] [20]", "SIMPLE_CHEMICAL", 121, 170]]], ["The feature extraction is another important part of Iris recognition discussed in some researches [3, 7, 10] .", [["The feature extraction", "TREATMENT", 0, 22]]], ["The shape and texture features are useful for identifying the Iris region's geometric properties.", [["shape", "OBSERVATION_MODIFIER", 4, 9], ["texture", "OBSERVATION_MODIFIER", 14, 21], ["Iris", "OBSERVATION", 62, 66]]], ["In contrast, FFT and Wavelet feature mostly represent energy distributions and convergence at different frequencies and boundaries, making them helpful in quantifying the Iris region heterogeneity [21] [22] [23] [24] .", [["[21] [22] [23]", "CHEMICAL", 197, 211], ["FFT", "PROTEIN", 13, 16], ["FFT", "TEST", 13, 16], ["energy distributions", "PROBLEM", 54, 74], ["energy distributions", "OBSERVATION", 54, 74], ["Iris", "ANATOMY", 171, 175]]], ["Also, GLDM and GLCM features are useful for identifying and computing the textures for assessing the heterogeneity in Iris region textual details [25] [26] [27] [28] [29] .I. INTRODUCTIONIn this paper, we proposed a four-stage machine learningbased Iris recognition using eye images.", [["eye", "ANATOMY", 272, 275], ["eye", "ORGAN", 272, 275], ["GLDM", "PROTEIN", 6, 10], ["eye images", "TEST", 272, 282], ["Iris", "ANATOMY", 118, 122]]], ["In the first step, we implemented the Iris region segmentation function by applying two techniques of relative total variation and Coarse Iris Localization, improved by shearlet transform in the edge detection stage.", [["Iris region", "DNA", 38, 49], ["relative total variation", "TREATMENT", 102, 126], ["Coarse Iris Localization", "TEST", 131, 155], ["Iris", "ANATOMY", 38, 42], ["total variation", "OBSERVATION", 111, 126], ["Coarse Iris", "OBSERVATION", 131, 142], ["improved", "OBSERVATION_MODIFIER", 157, 165], ["edge", "OBSERVATION_MODIFIER", 195, 199]]], ["We also used Daugman's rubber sheet model to transfer the detected Iris region to a rectangular form.", [["Iris region", "DNA", 67, 78], ["Daugman's rubber sheet model", "TREATMENT", 13, 41], ["Iris", "ANATOMY", 67, 71]]], ["In the second step, we proposed a computation and analysis scheme to generate a feature pool of spatial and frequency components from each segmented Iris region.", [["a computation", "TEST", 32, 45], ["analysis scheme", "TEST", 50, 65], ["segmented", "ANATOMY_MODIFIER", 139, 148], ["Iris", "ANATOMY", 149, 153], ["region", "ANATOMY_MODIFIER", 154, 160]]], ["In the third step, we reduced the feature pool size to find the optimal feature fusion and remove less important features by employing the Kernel-PCA technique.", [["size", "OBSERVATION_MODIFIER", 47, 51]]], ["The final feature vector was fed to a multi-layer neural network, proposed in the fourth step.A. DatasetThe proposed approach's performance was evaluated on available databases CASIA-Iris-Interval version 4 under nearinfrared, including 100 people and ten eye images per person, 2000 images in total [30] .", [["multi-layer neural network", "ANATOMY", 38, 64], ["eye", "ANATOMY", 256, 259], ["neural network", "MULTI-TISSUE_STRUCTURE", 50, 64], ["people", "ORGANISM", 241, 247], ["eye", "ORGAN", 256, 259], ["people", "SPECIES", 241, 247], ["person", "SPECIES", 271, 277], ["a multi-layer neural network", "TREATMENT", 36, 64], ["CASIA", "TEST", 177, 182], ["neural network", "OBSERVATION", 50, 64], ["Iris", "ANATOMY", 183, 187]]], ["One close-up iris camera is used to capture Iris images of this dataset.", [["iris", "ORGAN", 13, 17], ["Iris images", "TEST", 44, 55], ["iris camera", "OBSERVATION", 13, 24]]], ["The camera, used in this dataset, employs a circular NIR LED array, with suitable luminous flux for the imaging.", [["a circular NIR LED array", "TREATMENT", 42, 66], ["the imaging", "TEST", 100, 111]]], ["Because of this novel design, the iris camera can capture very clear iris images (Fig.1 ).", [["iris", "ANATOMY", 34, 38], ["iris", "ANATOMY", 69, 73], ["iris", "TISSUE", 69, 73], ["the iris camera", "TEST", 30, 45], ["iris", "ANATOMY", 34, 38]]], ["CASIA-Iris-Interval is well-suited for analyzing the detailed texture features of iris images.B. Iris Region SegmentationThe preprocessing part consisted of enhancement, noise removal, and reflection removal.", [["iris", "ANATOMY", 82, 86], ["iris images", "MULTI-TISSUE_STRUCTURE", 82, 93], ["iris images", "TEST", 82, 93], ["enhancement", "PROBLEM", 157, 168], ["noise removal", "TREATMENT", 170, 183], ["reflection removal", "TREATMENT", 189, 207], ["Iris", "ANATOMY", 6, 10], ["iris", "ANATOMY", 82, 86], ["Iris", "ANATOMY", 97, 101], ["enhancement", "OBSERVATION_MODIFIER", 157, 168], ["noise removal", "OBSERVATION", 170, 183]]], ["Some factors, including angle and intensity of illumination source, can leave an undesirable effect on the quality of iris image and, as a result, on segmentation and recognition accuracy.", [["iris", "ANATOMY", 118, 122], ["Some factors", "PROBLEM", 0, 12], ["illumination source", "PROBLEM", 47, 66], ["iris image", "TEST", 118, 128], ["recognition accuracy", "TEST", 167, 187]]], ["To address this problem, the Single Scale Retinex (SSR) method and normalizing eye image illumination are proposed in [31] .B. Iris Region SegmentationAfter enhancement, we applied a median filter to the iris image to remove isolated noisy pixels (Fig. 2b ).", [["eye", "ANATOMY", 79, 82], ["iris", "ANATOMY", 204, 208], ["eye", "ORGAN", 79, 82], ["this problem", "PROBLEM", 11, 23], ["the Single Scale Retinex (SSR) method", "TREATMENT", 25, 62], ["Iris Region SegmentationAfter enhancement", "PROBLEM", 127, 168], ["a median filter", "TREATMENT", 181, 196], ["Iris", "ANATOMY", 127, 131], ["iris", "ANATOMY", 204, 208], ["noisy pixels", "OBSERVATION", 234, 246]]], ["Then we removed undesired reflection, which occurs under a lessconstrained imaging environment, by a thresholding process so that pixels whose gray levels are higher than the highest threshold were moderated (Fig. 2c) .", [["pixels whose gray levels", "TEST", 130, 154], ["higher", "OBSERVATION_MODIFIER", 159, 165]]], ["To identify iris boundaries and separate it from other parts like the pupil, and eyelids, we used an approach proposed in [32] .", [["iris", "ANATOMY", 12, 16], ["pupil", "ANATOMY", 70, 75], ["eyelids", "ANATOMY", 81, 88], ["iris", "TISSUE", 12, 16], ["pupil", "MULTI-TISSUE_STRUCTURE", 70, 75], ["eyelids", "ORGAN", 81, 88], ["an approach", "TREATMENT", 98, 109], ["iris", "OBSERVATION", 12, 16], ["pupil", "OBSERVATION", 70, 75], ["eyelids", "ANATOMY", 81, 88]]], ["This segmentation method, employing relative total variation and Coarse Iris Localization techniques, is able to segment the iris area in the target eye image effectively.", [["iris area", "ANATOMY", 125, 134], ["eye", "ANATOMY", 149, 152], ["iris area", "TISSUE", 125, 134], ["eye", "ORGAN", 149, 152], ["This segmentation method", "TEST", 0, 24], ["relative total variation", "TREATMENT", 36, 60], ["total", "OBSERVATION_MODIFIER", 45, 50], ["variation", "OBSERVATION_MODIFIER", 51, 60], ["Coarse Iris", "OBSERVATION", 65, 76], ["iris", "ANATOMY", 125, 129]]], ["However, it utilizes conventional edge detection techniques such as Canny and Sobel to find edges in the image.", [["conventional edge detection techniques", "TREATMENT", 21, 59]]], ["We replaced the edge detection function with a more accurate edge detection approach (Fig. 3 ) employing shearlet transforms [33] .", [["edge", "OBSERVATION_MODIFIER", 16, 20]]], ["After segmentation, we transferred each angular segmented region to a rectangular mapped image with the fixed size for all cases using Daugman's rubber sheet model (Fig. 5 and Fig. 6) , where radius r is between 0 and 1, and \u03b8 is 1 to 360 degree.C. Feature extractionIn this step, we used a scheme to extract 252 features from both the spatial and frequency domains including shape&density, Gray Level Difference Method (GLDM), Gray-Level Co-Occurrence Matrix (GLCM) method, Fast Fourier Transform (FFT), and Wavelet transform ( Fig. 8 and Fig. 9 ).", [["C.", "SPECIES", 246, 248], ["C.", "SPECIES", 246, 248], ["segmentation", "TEST", 6, 18], ["a rectangular mapped image", "TEST", 68, 94], ["Daugman's rubber sheet model", "TREATMENT", 135, 163], ["Feature extraction", "TREATMENT", 249, 267], ["shape&density", "PROBLEM", 376, 389], ["method", "TEST", 467, 473], ["Fast Fourier Transform (FFT)", "TREATMENT", 475, 503], ["Wavelet transform", "TEST", 509, 526], ["size", "OBSERVATION_MODIFIER", 110, 114], ["radius", "ANATOMY_MODIFIER", 192, 198]]], ["For each group and each subsection, we measured 14 features applying the same statistical calculations such as Area, Mean, Std, Max, Min, Mean Deviation, Energy, Entropy, Kurtosis, Skewness, Range, RMS, Median, and Uniformity resulting in 252 features for each iris region totally.", [["iris", "ANATOMY", 261, 265], ["Area", "TEST", 111, 115], ["Mean", "TEST", 117, 121], ["Kurtosis", "TEST", 171, 179]]], ["We performed GLCM and GLDM techniques in four different directions, and Wavelet transforms were also implemented in eight sub-bands.D. Feature reductionGiven the initial pool of 252 features, we used the Kernel-PCA technique to discard non-useful features and find an optimal feature fusion.", [["GLCM", "TEST", 13, 17], ["GLDM techniques", "TREATMENT", 22, 37], ["the Kernel-PCA technique", "TREATMENT", 200, 224], ["non-useful features", "PROBLEM", 236, 255], ["an optimal feature fusion", "PROBLEM", 265, 290], ["fusion", "OBSERVATION", 284, 290]]], ["By engaging the PCA technique performed in a kernel Hilbert space, and then select the most important features [34] , the original feature pool was converted to 100 new synthetic features (Fig. 10) .", [["the PCA technique", "TEST", 12, 29]]], ["We finally applied this new optimal feature vector in the classification and recognition step.E. Machine learning-based classifierFor the classification and recognition task, we implemented a multi-layer neural network (Fig. 10) using Keras library in python.", [["neural network", "MULTI-TISSUE_STRUCTURE", 204, 218], ["Keras library", "DNA", 235, 248], ["this new optimal feature vector", "TREATMENT", 19, 50], ["a multi-layer neural network (Fig.", "TREATMENT", 190, 224]]], ["Nowadays, neural networks and deep learning models are important parts of detection, prediction, classification, and recognition systems with different applications [35] [36] [37] [38] [39] [40] [41] .", [["neural networks", "ANATOMY", 10, 25], ["[35] [36] [37] [38] [39] [40]", "CHEMICAL", 165, 194], ["neural networks", "MULTI-TISSUE_STRUCTURE", 10, 25], ["[35] [36] [37] [38] [39] [40] [41]", "SIMPLE_CHEMICAL", 165, 199], ["deep", "ANATOMY_MODIFIER", 30, 34]]], ["Our designed model was built by applying two hidden layers (with 1000 and 400 neurons, respectively) followed by one output classifier with 200 output class labels matching to 200 people in our dataset.", [["neurons", "ANATOMY", 78, 85], ["people", "ORGANISM", 180, 186], ["people", "SPECIES", 180, 186]]], ["Also, we used drop-out techniques to decrease the risk of overfitting during the training process.", [["drop-out techniques", "TREATMENT", 14, 33], ["overfitting", "PROBLEM", 58, 69], ["the training process", "TREATMENT", 77, 97], ["overfitting", "OBSERVATION", 58, 69]]], ["The total number of pf parameters in this neural network model is 581,600, which is effectively lower than deep learning models usually used in classification and recognition tasks such as AlexNet, Vgg, GoogleNet, and ResNet.", [["neural network", "ANATOMY", 42, 56], ["neural network", "MULTI-TISSUE_STRUCTURE", 42, 56], ["AlexNet", "PROTEIN", 189, 196], ["Vgg", "PROTEIN", 198, 201], ["GoogleNet", "PROTEIN", 203, 212], ["ResNet", "PROTEIN", 218, 224], ["pf parameters", "TEST", 20, 33], ["this neural network model", "TEST", 37, 62], ["total", "OBSERVATION_MODIFIER", 4, 9]]], ["This map reveals that the Wavelet group has less dependence compared to other groups.", [["This map", "TEST", 0, 8], ["less dependence", "PROBLEM", 44, 59], ["less", "OBSERVATION_MODIFIER", 44, 48], ["dependence", "OBSERVATION_MODIFIER", 49, 59]]], ["Also, the histogram of correlation coefficients is shown in Fig. 11b indicates that the feature pool generated in our study can provide a comprehensive representation of the iris region because more than 80% of the correlation coefficient values were less than 0.5.A. Analysis of extracted featuresWe used the AUC value (Area under the ROC curve) as an indicator to compare the discrimination power of different single (e.g., RMS, mean_wavelet, std_GLDM) and group (e.g., Shape&Density, FFT, GLCM) features shown in Fig. 12 .", [["iris region", "ANATOMY", 174, 185], ["the histogram", "TEST", 6, 19], ["correlation coefficients", "TEST", 23, 47], ["our study", "TEST", 114, 123], ["the correlation coefficient values", "TEST", 211, 245], ["extracted features", "PROBLEM", 280, 298], ["the AUC value", "TEST", 306, 319], ["the ROC curve", "TEST", 332, 345], ["Shape&Density", "TEST", 472, 485], ["FFT", "TEST", 487, 490], ["iris", "ANATOMY", 174, 178]]], ["As seen, most of the features (148 out of 252) showed the AUC value of more than 0.6, while Entropy, Mean_FFT, and Energy_Wavelet are the top three features with an AUC value of 0.88\u00b10.06, 0.86\u00b10.07, 0.84\u00b10.08, respectively.", [["the features", "TEST", 17, 29], ["the AUC value", "TEST", 54, 67], ["Entropy", "TEST", 92, 99], ["Mean_FFT", "TEST", 101, 109], ["an AUC value", "TEST", 162, 174]]], ["Also, the FFT group recorded the best performance among the other features groups confirming the importance of frequency features compared to spatial features.", [["the FFT group", "TEST", 6, 19]]], ["In contrast, the lowest performance belonged to the GLCM group (Fig. 12b) .", [["GLCM", "CANCER", 52, 56]]], ["Fig. 13 shows the performance of the training process comparing validation and training loss function values converged at 35 epochs with a score value of 0.24 and the accuracy of 97.6% for the test set.", [["the training process", "TREATMENT", 33, 53], ["validation", "TEST", 64, 74], ["training loss function values", "TEST", 79, 108], ["a score value", "TEST", 137, 150], ["the accuracy", "TEST", 163, 175], ["the test set", "TEST", 189, 201]]], ["Table 1 shows the average performance of our proposed iris recognition scheme confirming that the synthetic optimal feature group (K-PCA features) achieves a considerably better performance than the best single feature in Fig. 12a .IV. CONCLUSION AND DISCUSSIONIn this study, we showed that our proposed machine learning scheme of iris region segmentation, feature extraction, and neural network classifier could accurately recognize and classify Iris images.", [["iris", "ANATOMY", 54, 58], ["iris region", "ANATOMY", 331, 342], ["neural network", "ANATOMY", 381, 395], ["this study", "TEST", 264, 274], ["iris region segmentation", "PROBLEM", 331, 355], ["feature extraction", "TREATMENT", 357, 375], ["Iris images", "TEST", 447, 458], ["iris", "ANATOMY", 331, 335]]], ["Unlike various previously proposed machine learning schemes that use the texture-based features in the spatial domain, we computed image features in both the spatial and frequency domains.", [["computed image features", "TEST", 122, 145]]], ["Also, since creating optimal and most effective image features is one of the most critical tasks in building machine learning-based classifiers, we investigated the importance of utilizing a data reduction method to select more correlated and optimal features.", [["a data reduction method", "TREATMENT", 189, 212], ["most effective", "OBSERVATION_MODIFIER", 33, 47]]], ["The results proved that our feature reduction method decreases the size of feature space and can replace the new smaller feature vector with more correlated information and a lower redundancy.", [["our feature reduction method", "TREATMENT", 24, 52], ["the new smaller feature vector", "PROBLEM", 105, 135], ["a lower redundancy", "PROBLEM", 173, 191], ["reduction", "OBSERVATION_MODIFIER", 36, 45], ["size", "OBSERVATION_MODIFIER", 67, 71], ["feature space", "OBSERVATION", 75, 88], ["new", "OBSERVATION_MODIFIER", 109, 112], ["smaller", "OBSERVATION_MODIFIER", 113, 120], ["lower redundancy", "OBSERVATION", 175, 191]]]], "f615c9b59875fb3ff171f18e3ce3077c4f4d77f8": [["IntroductionHuman respiratory tract infections represent a major public health problem because they are associated with a high rate of hospitalization, signi fi cant morbidity, and mortality.", [["respiratory tract", "ANATOMY", 18, 35], ["respiratory tract infections", "DISEASE", 18, 46], ["IntroductionHuman respiratory tract infections", "PROBLEM", 0, 46], ["signi fi cant morbidity", "PROBLEM", 152, 175], ["respiratory tract", "ANATOMY", 18, 35]]], ["They thus cause a considerable fi nancial burden on the health-care system throughout the world.", [["a considerable fi nancial burden", "PROBLEM", 16, 48], ["considerable", "OBSERVATION_MODIFIER", 18, 30], ["fi", "OBSERVATION_MODIFIER", 31, 33], ["nancial", "OBSERVATION_MODIFIER", 34, 41], ["burden", "OBSERVATION", 42, 48]]], ["The elderly and immunocompromised subjects with medical conditions are especially at high risk of developing severe course of infection and various complications.", [["infection", "DISEASE", 126, 135], ["medical conditions", "PROBLEM", 48, 66], ["infection", "PROBLEM", 126, 135], ["various complications", "PROBLEM", 140, 161], ["immunocompromised", "OBSERVATION", 16, 33], ["severe", "OBSERVATION_MODIFIER", 109, 115], ["infection", "OBSERVATION", 126, 135]]], ["The most common respiratory viruses are in fl uenza virus type A (IV-A) and B (IV-B), respiratory syncytial virus type A (RSV-A) and B (RSV-B), parain fl uenza virus type 1, 2 and 3 (PIV-1, -2, -3), human rhinoviruses (hRV), human metapneumoviruses (hMPV), adenoviruses (AdV), human coronaviruses (hCoV), human bocavirus (hBoV) and enteroviruses (EV) (Do et al. 2011 ) .", [["respiratory syncytial virus", "DISEASE", 86, 113], ["human bocavirus (hBoV) and enteroviruses", "DISEASE", 305, 345], ["fl uenza virus type A", "ORGANISM", 43, 64], ["IV-A", "CANCER", 66, 70], ["B (IV-B),", "ORGANISM", 76, 85], ["respiratory syncytial virus type A", "ORGANISM", 86, 120], ["RSV-A", "ORGANISM", 122, 127], ["B (RSV-B", "ORGANISM", 133, 141], ["parain fl uenza virus type 1", "ORGANISM", 144, 172], ["2", "GENE_OR_GENE_PRODUCT", 174, 175], ["3", "GENE_OR_GENE_PRODUCT", 180, 181], ["PIV-1", "ORGANISM", 183, 188], ["-2", "GENE_OR_GENE_PRODUCT", 190, 192], ["-3", "GENE_OR_GENE_PRODUCT", 194, 196], ["human", "ORGANISM", 199, 204], ["rhinoviruses", "ORGANISM", 205, 217], ["hRV", "ORGANISM", 219, 222], ["human", "ORGANISM", 225, 230], ["metapneumoviruses", "GENE_OR_GENE_PRODUCT", 231, 248], ["hMPV", "ORGANISM", 250, 254], ["adenoviruses", "ORGANISM", 257, 269], ["AdV", "ORGANISM", 271, 274], ["human", "ORGANISM", 277, 282], ["coronaviruses", "ORGANISM", 283, 296], ["hCoV", "GENE_OR_GENE_PRODUCT", 298, 302], ["human", "ORGANISM", 305, 310], ["bocavirus", "GENE_OR_GENE_PRODUCT", 311, 320], ["hBoV", "ORGANISM", 322, 326], ["enteroviruses", "ORGANISM", 332, 345], ["uenza virus", "SPECIES", 46, 57], ["respiratory syncytial virus", "SPECIES", 86, 113], ["RSV", "SPECIES", 122, 125], ["uenza virus type 1", "SPECIES", 154, 172], ["human", "SPECIES", 199, 204], ["human", "SPECIES", 225, 230], ["human", "SPECIES", 277, 282], ["human", "SPECIES", 305, 310], ["fl uenza virus type A (IV-A", "SPECIES", 43, 70], ["respiratory syncytial virus type A", "SPECIES", 86, 120], ["RSV-A", "SPECIES", 122, 127], ["RSV", "SPECIES", 136, 139], ["parain fl uenza virus type 1", "SPECIES", 144, 172], ["human rhinoviruses", "SPECIES", 199, 217], ["hRV", "SPECIES", 219, 222], ["human", "SPECIES", 225, 230], ["hMPV", "SPECIES", 250, 254], ["AdV", "SPECIES", 271, 274], ["human coronaviruses", "SPECIES", 277, 296], ["hCoV", "SPECIES", 298, 302], ["human", "SPECIES", 305, 310], ["hBoV", "SPECIES", 322, 326], ["The most common respiratory viruses", "PROBLEM", 0, 35], ["B (IV-B)", "TEST", 76, 84], ["respiratory syncytial virus", "PROBLEM", 86, 113], ["RSV", "TEST", 122, 125], ["B", "TEST", 133, 134], ["RSV", "TEST", 136, 139], ["parain fl uenza virus type", "TEST", 144, 170], ["PIV", "TEST", 183, 186], ["human rhinoviruses (hRV)", "PROBLEM", 199, 223], ["human metapneumoviruses (hMPV)", "PROBLEM", 225, 255], ["adenoviruses", "PROBLEM", 257, 269], ["human coronaviruses (hCoV", "TREATMENT", 277, 302], ["human bocavirus (hBoV", "PROBLEM", 305, 326], ["enteroviruses", "PROBLEM", 332, 345], ["respiratory viruses", "OBSERVATION", 16, 35], ["respiratory syncytial", "ANATOMY", 86, 107], ["rhinoviruses", "OBSERVATION", 205, 217]]], ["Infectious respiratory diseases caused by different viruses are characterized by a wide range of similar respiratory symptoms from mild cold to severe pneumonia.", [["respiratory", "ANATOMY", 11, 22], ["respiratory", "ANATOMY", 105, 116], ["Infectious respiratory diseases", "DISEASE", 0, 31], ["respiratory symptoms", "DISEASE", 105, 125], ["pneumonia", "DISEASE", 151, 160], ["Infectious respiratory diseases", "PROBLEM", 0, 31], ["different viruses", "PROBLEM", 42, 59], ["similar respiratory symptoms", "PROBLEM", 97, 125], ["mild cold to severe pneumonia", "PROBLEM", 131, 160], ["different", "OBSERVATION_MODIFIER", 42, 51], ["viruses", "OBSERVATION", 52, 59], ["wide", "OBSERVATION_MODIFIER", 83, 87], ["respiratory symptoms", "OBSERVATION", 105, 125], ["mild", "OBSERVATION_MODIFIER", 131, 135], ["severe", "OBSERVATION_MODIFIER", 144, 150], ["pneumonia", "OBSERVATION", 151, 160]]], ["This makes the clinical distinction between different agents involved in infection very dif fi cult.", [["infection", "DISEASE", 73, 82], ["infection", "PROBLEM", 73, 82], ["infection", "OBSERVATION", 73, 82]]], ["Although the high rates of infection with more than one respiratory virus have been reported, especially in children (Table 36.", [["infection", "DISEASE", 27, 36], ["children", "ORGANISM", 108, 116], ["children", "SPECIES", 108, 116], ["the high rates of infection", "PROBLEM", 9, 36], ["one respiratory virus", "PROBLEM", 52, 73], ["high", "OBSERVATION_MODIFIER", 13, 17], ["rates", "OBSERVATION_MODIFIER", 18, 23], ["infection", "OBSERVATION", 27, 36], ["virus", "OBSERVATION", 68, 73]]], ["3 ), the real number of co-infections is undoubtedly underestimated, mainly due to sensitivity of diagnostic methods 293 36 Co-Infections with In fl uenza and Other Respiratory Viruses used and limited number of tested viruses.", [["co-infections", "DISEASE", 24, 37], ["Infections", "DISEASE", 127, 137], ["Respiratory Viruses", "DISEASE", 165, 184], ["co-infections", "PROBLEM", 24, 37], ["diagnostic methods", "TEST", 98, 116], ["Co-Infections", "PROBLEM", 124, 137], ["fl uenza", "TEST", 146, 154], ["Other Respiratory Viruses", "PROBLEM", 159, 184], ["co-infections", "OBSERVATION", 24, 37], ["Respiratory Viruses", "OBSERVATION", 165, 184]]], ["In majority of cases the most likely or casual viral agents are tested fi rst and the diagnostics stops with a detection of the primary relevant infectious agent.", [["casual viral agents", "TREATMENT", 40, 59], ["most likely", "UNCERTAINTY", 25, 36], ["infectious", "OBSERVATION", 145, 155]]], ["Meanwhile rapid, reliable, and accurate identi fi cation of every viral pathogen involved in infection is crucial for patient management, surveillance, and control of infection, including the prevention of nosocomial transmission.IntroductionWidespread use of PCR-based methods and their excellent sensitivity and speci fi city contributed to a great improvement of diagnostics of respiratory infections.", [["respiratory", "ANATOMY", 381, 392], ["infection", "DISEASE", 93, 102], ["infection", "DISEASE", 167, 176], ["respiratory infections", "DISEASE", 381, 403], ["patient", "ORGANISM", 118, 125], ["patient", "SPECIES", 118, 125], ["every viral pathogen", "PROBLEM", 60, 80], ["infection", "PROBLEM", 93, 102], ["patient management", "TREATMENT", 118, 136], ["surveillance", "TEST", 138, 150], ["infection", "PROBLEM", 167, 176], ["nosocomial transmission", "PROBLEM", 206, 229], ["PCR", "TEST", 260, 263], ["respiratory infections", "PROBLEM", 381, 403], ["infection", "OBSERVATION", 93, 102], ["infection", "OBSERVATION", 167, 176], ["nosocomial", "OBSERVATION", 206, 216], ["respiratory", "ANATOMY", 381, 392], ["infections", "OBSERVATION", 393, 403]]], ["While single PCR assay enables a detection of only one target, the multiplex molecular methods provide a simultaneous detection of multiple viruses in the single reaction and thus give a more accurate diagnosis of causative pathogens and provide a better understanding of the etiology of infection.", [["infection", "DISEASE", 288, 297], ["single PCR assay", "TEST", 6, 22], ["a detection", "TEST", 31, 42], ["multiple viruses", "PROBLEM", 131, 147], ["the single reaction", "PROBLEM", 151, 170], ["causative pathogens", "PROBLEM", 214, 233], ["infection", "PROBLEM", 288, 297], ["multiple", "OBSERVATION_MODIFIER", 131, 139], ["viruses", "OBSERVATION", 140, 147], ["infection", "OBSERVATION", 288, 297]]], ["The main advantages of using multiplex reactions are time saving and reducing the use of reagents and specimens, and consequently the cost of analysis.", [["specimens", "ANATOMY", 102, 111], ["multiplex reactions", "TREATMENT", 29, 48], ["specimens", "TEST", 102, 111], ["analysis", "TEST", 142, 150], ["main", "OBSERVATION_MODIFIER", 4, 8]]], ["The Seeplex RV Detection Kit (Seegene Inc., Korea), used in our study, is a qualitative multiplex assay that detects 12 respiratory viruses including 11 types of RNA and one type of DNA virus: IV-A, IV-B, RSV-A, RSV-B, PIV-1, PIV-2, PIV-3, hRV, hMPV, Adv, hCoV OC43 and combined hCoV 229E/NL63.", [["respiratory viruses", "DISEASE", 120, 139], ["DNA", "CELLULAR_COMPONENT", 182, 185], ["IV-A", "GENE_OR_GENE_PRODUCT", 193, 197], ["IV-B", "ORGANISM", 199, 203], ["RSV-A", "ORGANISM", 205, 210], ["RSV-B", "ORGANISM", 212, 217], ["PIV-1", "ORGANISM", 219, 224], ["PIV-2", "ORGANISM", 226, 231], ["PIV-3", "ORGANISM", 233, 238], ["hRV", "GENE_OR_GENE_PRODUCT", 240, 243], ["hMPV", "ORGANISM", 245, 249], ["Adv", "GENE_OR_GENE_PRODUCT", 251, 254], ["hCoV", "GENE_OR_GENE_PRODUCT", 256, 260], ["NL63", "GENE_OR_GENE_PRODUCT", 289, 293], ["hRV", "DNA", 240, 243], ["Adv", "DNA", 251, 254], ["hCoV OC43", "DNA", 256, 265], ["hCoV 229E", "DNA", 279, 288], ["NL63", "DNA", 289, 293], ["RSV", "SPECIES", 205, 208], ["RSV", "SPECIES", 212, 215], ["hRV", "SPECIES", 240, 243], ["hMPV", "SPECIES", 245, 249], ["hCoV", "SPECIES", 256, 260], ["The Seeplex RV Detection", "TEST", 0, 24], ["our study", "TEST", 60, 69], ["a qualitative multiplex assay", "TEST", 74, 103], ["12 respiratory viruses", "PROBLEM", 117, 139], ["RNA", "TEST", 162, 165], ["DNA virus", "PROBLEM", 182, 191], ["IV", "TEST", 199, 201], ["RSV", "TEST", 205, 208], ["RSV", "TEST", 212, 215], ["PIV", "TEST", 219, 222], ["PIV", "TEST", 226, 229], ["PIV", "TEST", 233, 236], ["hRV", "TEST", 240, 243], ["hMPV", "PROBLEM", 245, 249], ["RV", "ANATOMY", 12, 14], ["respiratory viruses", "OBSERVATION", 120, 139], ["RSV", "ANATOMY", 205, 208], ["hMPV", "OBSERVATION", 245, 249], ["Adv", "ANATOMY", 251, 254]]], ["The assay uses dual priming oligonucleotide (DPO TM ) technology, which prevents non-speci fi c ampli fi cation (it generates consistently high speci fi city by blocking the extension of non-speci fi cally primed templates).", [["The assay", "TEST", 0, 9], ["dual priming oligonucleotide (DPO TM ) technology", "TREATMENT", 15, 64], ["ampli fi cation", "TREATMENT", 96, 111]]], ["The primers were designed for highly conserved regions in viral genome.IntroductionIn the epidemic season 2010/2011, the National In fl uenza Centre in Poland received 140 specimens (paid diagnostics) from hospitalized patients with respiratory tract infection, including 49 specimens from severe cases (i.e., patients from intensive care units, with pneumonia, respiratory failure, immunocompromised patients).", [["specimens", "ANATOMY", 172, 181], ["respiratory tract", "ANATOMY", 233, 250], ["specimens", "ANATOMY", 275, 284], ["respiratory", "ANATOMY", 362, 373], ["respiratory tract infection", "DISEASE", 233, 260], ["pneumonia", "DISEASE", 351, 360], ["respiratory failure", "DISEASE", 362, 381], ["patients", "ORGANISM", 219, 227], ["tract", "ORGANISM_SUBDIVISION", 245, 250], ["patients", "ORGANISM", 310, 318], ["patients", "ORGANISM", 401, 409], ["viral genome", "DNA", 58, 70], ["patients", "SPECIES", 219, 227], ["patients", "SPECIES", 310, 318], ["patients", "SPECIES", 401, 409], ["respiratory tract infection", "PROBLEM", 233, 260], ["severe cases", "PROBLEM", 290, 302], ["pneumonia", "PROBLEM", 351, 360], ["respiratory failure", "PROBLEM", 362, 381], ["viral genome", "OBSERVATION", 58, 70], ["respiratory tract", "ANATOMY", 233, 250], ["infection", "OBSERVATION", 251, 260], ["pneumonia", "OBSERVATION", 351, 360], ["respiratory failure", "OBSERVATION", 362, 381]]], ["In the majority of these specimens, hospitals required only detection of in fl uenza viruses (IV-A and IV-B (n = 29) or IV-A and subtype A(H1N1)2009 (n = 93)).", [["specimens", "ANATOMY", 25, 34], ["fl uenza viruses", "ORGANISM", 76, 92], ["IV-A", "CANCER", 120, 124], ["fl uenza viruses", "PROBLEM", 76, 92]]], ["Testing of specimens not only for in fl uenza, but also other respiratory viruses was commissioned only for 18 patients.", [["specimens", "ANATOMY", 11, 20], ["respiratory viruses", "DISEASE", 62, 81], ["specimens", "CANCER", 11, 20], ["patients", "ORGANISM", 111, 119], ["patients", "SPECIES", 111, 119], ["Testing of specimens", "TEST", 0, 20], ["other respiratory viruses", "PROBLEM", 56, 81], ["respiratory", "ANATOMY", 62, 73], ["viruses", "OBSERVATION", 74, 81]]], ["In these cases the multiplex Seeplex TM RV12 ACE Detection Kit was used to detect 12 respiratory viruses.", [["respiratory viruses", "DISEASE", 85, 104], ["the multiplex Seeplex TM", "TREATMENT", 15, 39], ["ACE Detection Kit", "TEST", 45, 62], ["12 respiratory viruses", "PROBLEM", 82, 104], ["respiratory viruses", "OBSERVATION", 85, 104]]], ["In our paper, we present fi ve cases of multiple infections caused by various respiratory viruses in immunocompromised patients.MethodsAll respiratory specimens (nasopharyngeal swabs) were suspended in 500 m l of physiological saline solution (within several hours after samples collection).", [["respiratory specimens", "ANATOMY", 139, 160], ["nasopharyngeal swabs", "ANATOMY", 162, 182], ["samples", "ANATOMY", 271, 278], ["infections", "DISEASE", 49, 59], ["respiratory viruses", "DISEASE", 78, 97], ["patients", "ORGANISM", 119, 127], ["nasopharyngeal swabs", "MULTI-TISSUE_STRUCTURE", 162, 182], ["patients", "SPECIES", 119, 127], ["multiple infections", "PROBLEM", 40, 59], ["various respiratory viruses", "PROBLEM", 70, 97], ["nasopharyngeal swabs", "TEST", 162, 182], ["physiological saline solution", "TREATMENT", 213, 242], ["samples collection", "TEST", 271, 289], ["multiple", "OBSERVATION_MODIFIER", 40, 48], ["infections", "OBSERVATION", 49, 59], ["respiratory viruses", "OBSERVATION", 78, 97]]], ["Viral nucleic acid was extracted from 140 m l of sample using the QIAamp Viral RNA Mini Kit (Qiagen, Germany), according to the manufacturer's instructions.", [["sample", "ANATOMY", 49, 55], ["nucleic acid", "CHEMICAL", 6, 18], ["Viral nucleic acid", "TEST", 0, 18], ["the QIAamp", "TREATMENT", 62, 72], ["nucleic acid", "OBSERVATION", 6, 18]]], ["The elution was performed with 60 m l of elution buffer. cDNA was synthesized by using First Strand cDNA Synthesis Kit with random hexamer primers (Fermentas, Lithuania).", [["cDNA", "DNA", 57, 61], ["The elution", "TREATMENT", 0, 11], ["elution buffer", "TREATMENT", 41, 55], ["First Strand cDNA Synthesis Kit", "TREATMENT", 87, 118], ["random hexamer primers", "TREATMENT", 124, 146]]], ["Reverse transcription reactions were performed in a fi nal volume of 20 m l with 1 m l of random hexamers, 5 m l of water, 5 m l of total nucleic acids extracted from clinical specimen, 4 m l of 5\u00d7 RT Buffer, 2 m l of dNTP Mix (10 mM each), 1 m l of RiboLock TM RNase Inhibitor and 2 m l of M-MuLV Reverse Transcriptase.", [["specimen", "ANATOMY", 176, 184], ["nucleic acids", "CHEMICAL", 138, 151], ["dNTP", "CHEMICAL", 218, 222], ["dNTP", "CHEMICAL", 218, 222], ["MuLV Reverse Transcriptase", "PROTEIN", 293, 319], ["Reverse transcription reactions", "PROBLEM", 0, 31], ["a fi nal volume", "TEST", 50, 65], ["random hexamers", "TREATMENT", 90, 105], ["total nucleic acids", "TREATMENT", 132, 151], ["clinical specimen", "TEST", 167, 184], ["RT Buffer", "TREATMENT", 198, 207], ["dNTP Mix", "TREATMENT", 218, 226], ["RiboLock TM RNase Inhibitor", "TREATMENT", 250, 277]]], ["After incubation for 5 min at 25\u00b0C, reverse transcription reactions were carried out for 60 min at 45\u00b0C, followed by inactivation of reverse transcriptase for 5 min at 70\u00b0C. The next step was multiplex reaction with using the Seeplex TM RV12 ACE Detection Kit (Seegene, Inc., Korea) containing A and B sets of primer.", [["reverse transcriptase", "PROTEIN", 133, 154], ["reverse transcription reactions", "PROBLEM", 36, 67], ["reverse transcriptase", "TREATMENT", 133, 154], ["multiplex reaction", "PROBLEM", 192, 210], ["the Seeplex TM", "TREATMENT", 222, 236], ["ACE Detection Kit", "TREATMENT", 242, 259], ["A and B sets of primer", "TREATMENT", 294, 316]]], ["Both panels were performed in 20 m l reaction volumes in accordance with the supplied protocols.", [["Both panels", "TEST", 0, 11], ["the supplied protocols", "TREATMENT", 73, 95]]], ["The internal ampli fi cation control for detection of inhibitor of PCR, positive control (a mixture of 12 pathogens and internal control clones from the manufacturer as a template) and negative control (sterilized water instead of a template) were included in each reaction.", [["The internal ampli fi cation control", "TREATMENT", 0, 36], ["inhibitor of PCR", "TREATMENT", 54, 70], ["pathogens", "PROBLEM", 106, 115], ["internal control clones", "TREATMENT", 120, 143], ["a template)", "TREATMENT", 231, 242]]], ["After ampli fi cation, the obtained PCR products were analyzed by electrophoresis in 2% agarose gel stained with GelRed TM 10,000\u00d7 solution.", [["agarose", "SIMPLE_CHEMICAL", 88, 95], ["ampli fi cation", "TREATMENT", 6, 21], ["the obtained PCR products", "TREATMENT", 23, 48], ["electrophoresis", "TEST", 66, 81], ["GelRed TM", "TREATMENT", 113, 122]]], ["The respiratory viruses were identi fi ed by comparison of amplicons with bands included in the positive control and molecular size marker for set A or B provided by the manufacturer and consisting of seven bands with the same length as PCR products for internal control and six appropriate viruses.MethodsThe results positive for in fl uenza type B were con fi rmed by further analysis by one-step real-time RT-PCR assay according to CDC rRT-PCR Protocol (version 2007) and those positive for in fl uenza A were tested by RealTime ready In fl uenza A/H1N1 Detection Set (Roche Diagnostics, Switzerland) with using primer set only for detection of type A (M2).", [["The respiratory viruses", "PROBLEM", 0, 23], ["bands", "PROBLEM", 74, 79], ["seven bands", "PROBLEM", 201, 212], ["PCR products", "TREATMENT", 237, 249], ["internal control", "TREATMENT", 254, 270], ["further analysis", "TEST", 370, 386], ["PCR assay", "TEST", 412, 421], ["respiratory", "ANATOMY", 4, 15], ["viruses", "OBSERVATION", 16, 23], ["size", "OBSERVATION_MODIFIER", 127, 131], ["viruses", "OBSERVATION", 291, 298]]], ["Specimens with laboratory results indicative RSV-A or/and RSV-B were con fi rmed by one-step RT-PCR using Transcriptor One-Step RT-PCR Kit (Roche Diagnostics, Switzerland) and primers: 5' -TGTTATAGGCATATCATTGA -3' and 5' -TTAACCAGCAAAGTGTTAGA -3' described by Gr\u00f6ndahl et al. ( 1999 ) .", [["Specimens", "ANATOMY", 0, 9], ["RSV-A", "ORGANISM", 45, 50], ["RSV-B", "ORGANISM", 58, 63], ["RSV-A", "SPECIES", 45, 50], ["RSV-B", "SPECIES", 58, 63], ["Specimens", "TEST", 0, 9], ["RSV", "TEST", 45, 48], ["RSV", "PROBLEM", 58, 61], ["PCR", "TEST", 96, 99], ["TGTTATAGGCATATCATTGA", "TREATMENT", 189, 209]]], ["Ampli fi cation was carried out in a 25 m l reaction volume, including 5 m l of 5 \u00d7 Transcriptor buffer, 0.4 m M of each primer, 0.5 m l of enzyme, 5 m l of extracted template and water to a fi nal volume.", [["Ampli fi cation", "SIMPLE_CHEMICAL", 0, 15], ["enzyme", "PROTEIN", 140, 146], ["Ampli fi cation", "TREATMENT", 0, 15], ["a 25 m l reaction volume", "TREATMENT", 35, 59], ["Transcriptor buffer", "TREATMENT", 84, 103], ["enzyme", "TEST", 140, 146], ["a fi nal volume", "TREATMENT", 189, 204]]], ["Cycling reaction was performed in a Veriti\u2122 96-Well Thermal Cycler (Applied Biosystems Inc., USA) as follows: a single cycle of reverse transcription for 30 min. at 50\u00b0C and reverse transcriptase inactivation and initial denaturation for 7 min at 94\u00b0C, than 45 cycles of denaturation at 94\u00b0C for 10 s, annealing at 55\u00b0C for 30 s and extension at 68\u00b0C for 55 s.", [["C", "SIMPLE_CHEMICAL", 168, 169], ["reverse transcriptase", "PROTEIN", 174, 195], ["Cycling reaction", "PROBLEM", 0, 16], ["reverse transcription", "TREATMENT", 128, 149], ["reverse transcriptase inactivation", "PROBLEM", 174, 208], ["initial denaturation", "PROBLEM", 213, 233], ["denaturation", "TREATMENT", 271, 283], ["transcriptase inactivation", "OBSERVATION", 182, 208]]], ["After the last cycle, the reaction was completed by a fi nal extension at 68\u00b0C for 7 min.", [["the reaction", "PROBLEM", 22, 34], ["a fi nal extension", "TREATMENT", 52, 70]]], ["Ampli fi cation products (20 m l) were separated in 1.5% agarose gel stained with GelRed TM 10,000\u00d7 solution in 1 \u00d7 TAE buffer.", [["GelRed", "CHEMICAL", 82, 88], ["TAE", "CHEMICAL", 116, 119], ["agarose", "SIMPLE_CHEMICAL", 57, 64], ["Ampli fi cation products", "TREATMENT", 0, 24], ["GelRed TM", "TREATMENT", 82, 91]]], ["GeneRuler TM 100 bp DNA Ladders was used for estimating the molecular size weight of the obtained bands (Fermentas, Lithuania).", [["DNA", "CELLULAR_COMPONENT", 20, 23], ["GeneRuler TM 100 bp DNA Ladders", "DNA", 0, 31], ["bp DNA Ladders", "TREATMENT", 17, 31], ["size", "OBSERVATION_MODIFIER", 70, 74]]], ["Clinical specimens, isolated nucleic acids, and cDNA were stored at \u221270\u00b0C.ResultsTen out of the 18 respiratory specimens were positive for at least one respiratory virus.", [["specimens", "ANATOMY", 9, 18], ["respiratory specimens", "ANATOMY", 99, 120], ["nucleic acids", "CHEMICAL", 29, 42], ["cDNA", "DNA", 48, 52], ["Clinical specimens", "TEST", 0, 18], ["isolated nucleic acids", "TEST", 20, 42], ["the 18 respiratory specimens", "TEST", 92, 120], ["one respiratory virus", "PROBLEM", 148, 169], ["respiratory virus", "OBSERVATION", 152, 169]]], ["Single infections were found in fi ve cases and were caused by IV-A (three cases) and RSV-B (two cases).", [["infections", "DISEASE", 7, 17], ["RSV-B", "DISEASE", 86, 91], ["IV-A", "GENE_OR_GENE_PRODUCT", 63, 67], ["RSV-B", "ORGANISM", 86, 91], ["IV-A", "SPECIES", 63, 67], ["RSV-B", "SPECIES", 86, 91], ["Single infections", "PROBLEM", 0, 17], ["RSV", "PROBLEM", 86, 89], ["infections", "OBSERVATION", 7, 17]]], ["Co-infections (infections with two or more viruses) were found in fi ve patients: double infections were identi fi ed in two cases, one patient was co-infected with four different viral pathogens, and in other two patients multiple infections caused by fi ve viral agents was detected.", [["Co-infections", "DISEASE", 0, 13], ["infections", "DISEASE", 15, 25], ["infections", "DISEASE", 89, 99], ["viral pathogens", "DISEASE", 180, 195], ["infections", "DISEASE", 232, 242], ["patients", "ORGANISM", 72, 80], ["patient", "ORGANISM", 136, 143], ["patients", "ORGANISM", 214, 222], ["patients", "SPECIES", 72, 80], ["patient", "SPECIES", 136, 143], ["patients", "SPECIES", 214, 222], ["Co-infections (infections", "PROBLEM", 0, 25], ["double infections", "PROBLEM", 82, 99], ["co-infected", "PROBLEM", 148, 159], ["four different viral pathogens", "PROBLEM", 165, 195], ["multiple infections", "PROBLEM", 223, 242], ["fi ve viral agents", "TREATMENT", 253, 271], ["infections", "OBSERVATION", 89, 99], ["viral pathogens", "OBSERVATION", 180, 195], ["multiple", "OBSERVATION_MODIFIER", 223, 231], ["infections", "OBSERVATION", 232, 242], ["viral agents", "OBSERVATION", 259, 271]]], ["Table 36 .1 shows the pathogens involved in multiple infections.ResultsFour co-infected patients (P1, P2, P3, and P4) were hospitalized in the same hospital and Department.", [["infections", "DISEASE", 53, 63], ["patients", "ORGANISM", 88, 96], ["patients", "SPECIES", 88, 96], ["the pathogens", "PROBLEM", 18, 31], ["multiple infections", "PROBLEM", 44, 63], ["multiple", "OBSERVATION_MODIFIER", 44, 52], ["infections", "OBSERVATION", 53, 63]]], ["The swabs were collected on the 4th of March 2011 (from patients P1 and P2) and the 11th of March 2011 (from patients P3 and P4).", [["swabs", "ANATOMY", 4, 9], ["patients", "ORGANISM", 56, 64], ["patients", "ORGANISM", 109, 117], ["patients", "SPECIES", 56, 64], ["patients", "SPECIES", 109, 117], ["The swabs", "TEST", 0, 9]]], ["Patient 5 was hospitalized in another hospital and the swab was collected on the 3rd of February 2011.", [["swab", "ANATOMY", 55, 59], ["Patient", "SPECIES", 0, 7], ["the swab", "TEST", 51, 59]]], ["All fi ve patients were immunosuppressed, including one child (4-year-old boy) and have different underlying chronic diseases (Table 36 .2 ).", [["chronic diseases", "DISEASE", 109, 125], ["patients", "ORGANISM", 10, 18], ["boy", "ORGANISM", 74, 77], ["patients", "SPECIES", 10, 18], ["boy", "SPECIES", 74, 77], ["different underlying chronic diseases", "PROBLEM", 88, 125], ["immunosuppressed", "OBSERVATION", 24, 40], ["chronic", "OBSERVATION_MODIFIER", 109, 116], ["diseases", "OBSERVATION", 117, 125]]], ["Only two patients (P1 and P3 with co-infections caused by IV-A, IV-B and three other viruses) developed symptoms of acute respiratory infection with signs of bronchial obturation and they required longer antiviral therapy.", [["respiratory", "ANATOMY", 122, 133], ["bronchial", "ANATOMY", 158, 167], ["co-infections", "DISEASE", 34, 47], ["respiratory infection", "DISEASE", 122, 143], ["patients", "ORGANISM", 9, 17], ["IV-B", "ORGANISM", 64, 68], ["bronchial", "ORGAN", 158, 167], ["patients", "SPECIES", 9, 17], ["co-infections", "PROBLEM", 34, 47], ["IV-B and three other viruses", "TREATMENT", 64, 92], ["symptoms", "PROBLEM", 104, 112], ["acute respiratory infection", "PROBLEM", 116, 143], ["bronchial obturation", "PROBLEM", 158, 178], ["longer antiviral therapy", "TREATMENT", 197, 221], ["acute", "OBSERVATION_MODIFIER", 116, 121], ["respiratory", "ANATOMY", 122, 133], ["infection", "OBSERVATION", 134, 143], ["bronchial", "ANATOMY", 158, 167], ["obturation", "OBSERVATION", 168, 178], ["antiviral therapy", "OBSERVATION", 204, 221]]], ["One of them (P1) was mechanically ventilated for 3 days.", [["mechanically ventilated", "PROBLEM", 21, 44], ["mechanically", "OBSERVATION_MODIFIER", 21, 33], ["ventilated", "OBSERVATION", 34, 44]]], ["The condition of the remaining patients was medium or good.", [["patients", "ORGANISM", 31, 39], ["patients", "SPECIES", 31, 39]]], ["Three patients received oseltamivir, one oseltamivir and then zanamivir, one patient received antibiotics and no antiviral drugs.", [["oseltamivir", "CHEMICAL", 24, 35], ["oseltamivir", "CHEMICAL", 41, 52], ["zanamivir", "CHEMICAL", 62, 71], ["oseltamivir", "CHEMICAL", 24, 35], ["oseltamivir", "CHEMICAL", 41, 52], ["zanamivir", "CHEMICAL", 62, 71], ["patients", "ORGANISM", 6, 14], ["oseltamivir", "SIMPLE_CHEMICAL", 24, 35], ["oseltamivir", "SIMPLE_CHEMICAL", 41, 52], ["zanamivir", "SIMPLE_CHEMICAL", 62, 71], ["patient", "ORGANISM", 77, 84], ["patients", "SPECIES", 6, 14], ["patient", "SPECIES", 77, 84], ["oseltamivir", "TREATMENT", 24, 35], ["one oseltamivir", "TREATMENT", 37, 52], ["zanamivir", "TREATMENT", 62, 71], ["antibiotics", "TREATMENT", 94, 105], ["antiviral drugs", "TREATMENT", 113, 128]]], ["The condition of two patients after therapy was medium, although one of them received oseltamivir.", [["oseltamivir", "CHEMICAL", 86, 97], ["oseltamivir", "CHEMICAL", 86, 97], ["patients", "ORGANISM", 21, 29], ["oseltamivir", "SIMPLE_CHEMICAL", 86, 97], ["patients", "SPECIES", 21, 29], ["therapy", "TREATMENT", 36, 43], ["oseltamivir", "TREATMENT", 86, 97]]], ["In this patient mixed infection with fi ve viral agents: IV-A, IV-B, RSV-A, RSV-B, and PIV-3 were con fi rmed.ResultsMonoplex PCR with different primer sets for detection of IV-A, IV-B and RSV-A/B (without identi fi cation of subtype) showed the results consistent with multiplex Seeplex PCR.", [["infection", "DISEASE", 22, 31], ["patient", "ORGANISM", 8, 15], ["IV-A", "ORGANISM", 57, 61], ["IV-B", "ORGANISM", 63, 67], ["RSV-A", "ORGANISM", 69, 74], ["RSV-B", "ORGANISM", 76, 81], ["PIV-3", "ORGANISM", 87, 92], ["IV-A", "GENE_OR_GENE_PRODUCT", 174, 178], ["IV-B", "GENE_OR_GENE_PRODUCT", 180, 184], ["RSV-A/B", "ORGANISM", 189, 196], ["con fi rmed", "DNA", 98, 109], ["patient", "SPECIES", 8, 15], ["RSV", "SPECIES", 69, 72], ["RSV", "SPECIES", 76, 79], ["RSV-A", "SPECIES", 189, 194], ["this patient mixed infection", "PROBLEM", 3, 31], ["fi ve viral agents", "TREATMENT", 37, 55], ["IV", "TREATMENT", 63, 65], ["RSV", "TREATMENT", 69, 72], ["RSV", "PROBLEM", 76, 79], ["PIV", "TREATMENT", 87, 90], ["Monoplex PCR", "TEST", 117, 129], ["IV", "TEST", 174, 176], ["IV", "TEST", 180, 182], ["RSV", "PROBLEM", 189, 192], ["multiplex Seeplex PCR", "PROBLEM", 270, 291], ["mixed", "OBSERVATION_MODIFIER", 16, 21], ["infection", "OBSERVATION", 22, 31], ["RSV", "ANATOMY", 69, 72], ["PIV", "ANATOMY", 87, 90], ["RSV", "ANATOMY", 189, 192], ["consistent with", "UNCERTAINTY", 254, 269]]], ["In case of Patient 2, a second specimen (bronchoalveolar lavage) was collected on the 23rd of March 2011 and the result was positive for RSV-B and negative for the other pathogens, including IV-A and RSV-A, which were detected in the previous specimen.DiscussionConventional methods of diagnostics of viral respiratory infections base mainly on virus isolation by cell culture, antigen detection, and serological assays.", [["specimen", "ANATOMY", 31, 39], ["bronchoalveolar lavage", "ANATOMY", 41, 63], ["specimen", "ANATOMY", 243, 251], ["respiratory", "ANATOMY", 307, 318], ["cell", "ANATOMY", 364, 368], ["viral respiratory infections", "DISEASE", 301, 329], ["bronchoalveolar lavage", "MULTI-TISSUE_STRUCTURE", 41, 63], ["RSV-B", "ORGANISM", 137, 142], ["IV-A", "GENE_OR_GENE_PRODUCT", 191, 195], ["RSV-A", "ORGANISM", 200, 205], ["cell", "CELL", 364, 368], ["Patient", "SPECIES", 11, 18], ["RSV", "SPECIES", 137, 140], ["IV-A", "SPECIES", 191, 195], ["RSV-A", "SPECIES", 200, 205], ["a second specimen (bronchoalveolar lavage", "TEST", 22, 63], ["RSV", "PROBLEM", 137, 140], ["the other pathogens", "PROBLEM", 160, 179], ["RSV", "PROBLEM", 200, 203], ["viral respiratory infections base", "PROBLEM", 301, 334], ["virus isolation", "TREATMENT", 345, 360], ["cell culture", "TEST", 364, 376], ["antigen detection", "TEST", 378, 395], ["serological assays", "TEST", 401, 419], ["viral", "OBSERVATION_MODIFIER", 301, 306], ["respiratory infections", "OBSERVATION", 307, 329]]], ["Cell culture has been considered as the gold standard for virus diagnosis but is not adapted to all medically important respiratory viruses.", [["Cell", "ANATOMY", 0, 4], ["Cell", "CELL", 0, 4], ["Cell culture", "TEST", 0, 12], ["virus diagnosis", "TEST", 58, 73], ["respiratory viruses", "OBSERVATION", 120, 139]]], ["In contrast to this method, PCR permits rapid detection of viruses that are dif fi cult to culture or have not been well replicated in vitro , such as hMPV, hCoV NL63 and hRV, with excellent sensitivity and specify (Calvo et al. 2008 ) .", [["hMPV", "ORGANISM", 151, 155], ["hCoV", "GENE_OR_GENE_PRODUCT", 157, 161], ["hRV", "GENE_OR_GENE_PRODUCT", 171, 174], ["hMPV", "SPECIES", 151, 155], ["hCoV", "SPECIES", 157, 161], ["hRV", "SPECIES", 171, 174], ["this method", "TEST", 15, 26], ["PCR", "TEST", 28, 31], ["viruses", "PROBLEM", 59, 66], ["fi cult", "TEST", 80, 87], ["culture", "TEST", 91, 98], ["hMPV", "TEST", 151, 155], ["hRV", "TEST", 171, 174], ["viruses", "OBSERVATION", 59, 66]]], ["Additionally, viruses present in specimens may considerably differ with viral loads and rate of replication, and this would make the detection of slowly replicating pathogens dif fi cult.", [["specimens", "ANATOMY", 33, 42], ["specimens", "CANCER", 33, 42], ["viruses", "PROBLEM", 14, 21], ["viral loads", "PROBLEM", 72, 83], ["viruses", "OBSERVATION", 14, 21]]], ["Therefore, numerous studies have been developed over recent years to evaluate the PCRbased methods for detection and typing/subtyping of respiratory viruses (Templeton et al. 2004 ; Bellau-Pujol et al. 2005 ; Gunson et al. 2005 ; Wu et al. 2008 ) .", [["respiratory viruses", "DISEASE", 137, 156], ["numerous studies", "TEST", 11, 27], ["detection", "TEST", 103, 112], ["typing", "TEST", 117, 123], ["respiratory viruses", "PROBLEM", 137, 156], ["respiratory viruses", "OBSERVATION", 137, 156]]], ["When a viral infection is taken into consideration, because of very similar and nonspeci fi c clinical symptoms caused by various respiratory viruses, the list of possible etiologic agents is very long.", [["viral infection", "DISEASE", 7, 22], ["respiratory viruses", "DISEASE", 130, 149], ["a viral infection", "PROBLEM", 5, 22], ["clinical symptoms", "PROBLEM", 94, 111], ["various respiratory viruses", "PROBLEM", 122, 149], ["viral", "OBSERVATION_MODIFIER", 7, 12], ["infection", "OBSERVATION", 13, 22], ["respiratory viruses", "OBSERVATION", 130, 149]]], ["In contrast to monoplex PCR reaction, the use of multiplex PCR allows detecting various respiratory pathogens in a single reaction, including the identi fi cation of the type and the detection of co-infections with multiple agents, which could be missed by the monoplex reaction.", [["respiratory pathogens", "DISEASE", 88, 109], ["co-infections", "DISEASE", 196, 209], ["monoplex PCR reaction", "PROBLEM", 15, 36], ["multiplex PCR", "TEST", 49, 62], ["various respiratory pathogens", "PROBLEM", 80, 109], ["a single reaction", "PROBLEM", 113, 130], ["the identi fi cation", "TREATMENT", 142, 162], ["co-infections", "PROBLEM", 196, 209], ["multiple agents", "TREATMENT", 215, 230], ["the monoplex reaction", "PROBLEM", 257, 278], ["respiratory pathogens", "OBSERVATION", 88, 109], ["co-infections", "OBSERVATION", 196, 209]]], ["The introduction of multiplex PCR to routine diagnostics revealed a higher prevalence of co-infections than has previously been reported by conventional techniques (Freymuth et al. 1997 ) .", [["co-infections", "DISEASE", 89, 102], ["multiplex PCR", "TEST", 20, 33], ["routine diagnostics", "TEST", 37, 56], ["co-infections", "PROBLEM", 89, 102], ["co-infections", "OBSERVATION", 89, 102]]], ["A review of the literature indicates that the rate of co-infections may range from approximately 15 to as high as 50% of all positive specimens (Table 36 .3 ).", [["specimens", "ANATOMY", 134, 143], ["co-infections", "DISEASE", 54, 67], ["the rate of co-infections", "PROBLEM", 42, 67], ["co-infections", "OBSERVATION", 54, 67]]], ["The majority of papers presenting the results of molecular assays for simultaneous detection of respiratory viruses and mixed infections focus on pediatric patients, infants, and young children in whom viral shedding in the respiratory tract is usually much higher.", [["respiratory tract", "ANATOMY", 224, 241], ["respiratory viruses", "DISEASE", 96, 115], ["infections", "DISEASE", 126, 136], ["patients", "ORGANISM", 156, 164], ["infants", "ORGANISM", 166, 173], ["children", "ORGANISM", 185, 193], ["respiratory tract", "ORGANISM_SUBDIVISION", 224, 241], ["patients", "SPECIES", 156, 164], ["infants", "SPECIES", 166, 173], ["children", "SPECIES", 185, 193], ["molecular assays", "TEST", 49, 65], ["respiratory viruses", "PROBLEM", 96, 115], ["mixed infections", "PROBLEM", 120, 136], ["viral shedding in the respiratory tract", "PROBLEM", 202, 241], ["respiratory viruses", "OBSERVATION", 96, 115], ["mixed", "OBSERVATION_MODIFIER", 120, 125], ["infections", "OBSERVATION", 126, 136], ["respiratory tract", "ANATOMY", 224, 241]]], ["In these patients, the respiratory syncytial viruses were the most common pathogen occurred in respiratory viral co-infection, the next most often identi fi ed viruses in mixed infection were hRV, PIV, hMPV, and others.", [["respiratory syncytial viruses", "DISEASE", 23, 52], ["respiratory viral co-infection", "DISEASE", 95, 125], ["infection", "DISEASE", 177, 186], ["patients", "ORGANISM", 9, 17], ["respiratory syncytial viruses", "ORGANISM", 23, 52], ["identi fi ed viruses", "ORGANISM", 147, 167], ["hMPV", "ORGANISM", 202, 206], ["patients", "SPECIES", 9, 17], ["respiratory syncytial viruses", "SPECIES", 23, 52], ["hRV", "SPECIES", 192, 195], ["PIV", "SPECIES", 197, 200], ["hMPV", "SPECIES", 202, 206], ["the respiratory syncytial viruses", "PROBLEM", 19, 52], ["respiratory viral co-infection", "PROBLEM", 95, 125], ["mixed infection", "PROBLEM", 171, 186], ["PIV", "TREATMENT", 197, 200], ["hMPV", "TREATMENT", 202, 206], ["respiratory", "ANATOMY", 23, 34], ["syncytial viruses", "OBSERVATION", 35, 52], ["respiratory", "OBSERVATION", 95, 106], ["viral co-infection", "OBSERVATION", 107, 125], ["mixed", "OBSERVATION_MODIFIER", 171, 176], ["infection", "OBSERVATION", 177, 186]]], ["There also are observed co-infections with different subtypes of in fl uenza A virus (Pajak et al. 2011 ) .", [["fl uenza A virus", "ORGANISM", 68, 84], ["uenza A virus", "SPECIES", 71, 84], ["fl uenza A virus", "SPECIES", 68, 84], ["observed co-infections", "PROBLEM", 15, 37], ["co-infections", "OBSERVATION", 24, 37], ["different subtypes", "OBSERVATION_MODIFIER", 43, 61], ["fl uenza", "OBSERVATION", 68, 76]]], ["The Seeplex TM RV Detection Kit has recently been found as a good tool for the detection of multiple infections caused by common respiratory viruses (Yoo et al. 2007 ; Do et al. 2011 ) , with sensitivity higher than viral culture assays (Drews et al. 2008 ; Roh et al. 2008 ; Kim et al. 2009 ; Lee et al. 2010 ) .", [["infections", "DISEASE", 101, 111], ["respiratory viruses", "DISEASE", 129, 148], ["The Seeplex TM RV Detection Kit", "TEST", 0, 31], ["multiple infections", "PROBLEM", 92, 111], ["common respiratory viruses", "PROBLEM", 122, 148], ["sensitivity", "TEST", 192, 203], ["viral culture assays", "TEST", 216, 236], ["multiple", "OBSERVATION_MODIFIER", 92, 100], ["infections", "OBSERVATION", 101, 111], ["respiratory viruses", "OBSERVATION", 129, 148]]], ["Our fi ndings con fi rmed that co-infections are not a rare occurrence, particularly in immunocompromised patients with medical conditions receiving immunosuppressive therapy.", [["patients", "ORGANISM", 106, 114], ["patients", "SPECIES", 106, 114], ["co-infections", "PROBLEM", 31, 44], ["medical conditions", "TREATMENT", 120, 138], ["immunosuppressive therapy", "TREATMENT", 149, 174], ["co-infections", "OBSERVATION", 31, 44]]], ["Nevertheless, a limitation of this study is a low number of tested specimens (18 specimens) that does not allow making more signi fi cant observations, especially the comparison of clinical and epidemiological features between patients with single infection and patients with multiple infections.DiscussionA rapid and accurate identi fi cation of etiologic agents involved in a respiratory infection is of essential clinical value.", [["specimens", "ANATOMY", 67, 76], ["specimens", "ANATOMY", 81, 90], ["respiratory", "ANATOMY", 378, 389], ["infection", "DISEASE", 248, 257], ["infections", "DISEASE", 285, 295], ["respiratory infection", "DISEASE", 378, 399], ["specimens", "CANCER", 67, 76], ["patients", "ORGANISM", 227, 235], ["patients", "ORGANISM", 262, 270], ["patients", "SPECIES", 227, 235], ["patients", "SPECIES", 262, 270], ["this study", "TEST", 30, 40], ["single infection", "PROBLEM", 241, 257], ["multiple infections", "PROBLEM", 276, 295], ["etiologic agents", "TREATMENT", 347, 363], ["a respiratory infection", "PROBLEM", 376, 399], ["infection", "OBSERVATION", 248, 257], ["multiple", "OBSERVATION_MODIFIER", 276, 284], ["infections", "OBSERVATION", 285, 295], ["respiratory", "ANATOMY", 378, 389], ["infection", "OBSERVATION", 390, 399]]], ["This may support the physician's decision regarding the selection of appropriate treatment and a prompt use of antiviral drugs, such as neuraminidase inhibitors in case of in fl uenza infections, for a patient, the exposed family members, or contact persons.", [["infections", "DISEASE", 184, 194], ["fl uenza", "ORGANISM", 175, 183], ["patient", "ORGANISM", 202, 209], ["persons", "ORGANISM", 250, 257], ["patient", "SPECIES", 202, 209], ["persons", "SPECIES", 250, 257], ["appropriate treatment", "TREATMENT", 69, 90], ["antiviral drugs", "TREATMENT", 111, 126], ["neuraminidase inhibitors", "TREATMENT", 136, 160], ["fl uenza infections", "PROBLEM", 175, 194]]], ["Clinicians are inclined to use antibiotics in cases when the etiological agent of infection is not identi fi ed.", [["infection", "DISEASE", 82, 91], ["antibiotics", "TREATMENT", 31, 42], ["infection", "PROBLEM", 82, 91], ["infection", "OBSERVATION", 82, 91]]], ["Therefore, in spite of lack of speci fi c antiviral drugs and the symptomatic and supportive treatment in majority of respiratory viral infections, a rapid detection of viral pathogen may help avoid an inappropriate use of antibiotics.", [["respiratory viral infections", "DISEASE", 118, 146], ["speci fi c", "GENE_OR_GENE_PRODUCT", 31, 41], ["speci fi", "TREATMENT", 31, 39], ["antiviral drugs", "TREATMENT", 42, 57], ["the symptomatic", "PROBLEM", 62, 77], ["supportive treatment", "TREATMENT", 82, 102], ["respiratory viral infections", "PROBLEM", 118, 146], ["a rapid detection", "TEST", 148, 165], ["viral pathogen", "PROBLEM", 169, 183], ["antibiotics", "TREATMENT", 223, 234], ["symptomatic", "OBSERVATION_MODIFIER", 66, 77], ["viral infections", "OBSERVATION", 130, 146]]], ["Moreover, the multiplex methods that enable detection of a broad spectrum of common viral pathogens are clinically desirable in case of speci fi c groups of patients: children, the elderly, and immunocompromised individuals who tend to have prolonged virus shedding and who are at increased risk of serious complications and mortality.", [["speci fi c", "GENE_OR_GENE_PRODUCT", 136, 146], ["patients", "ORGANISM", 157, 165], ["children", "ORGANISM", 167, 175], ["individuals", "ORGANISM", 212, 223], ["patients", "SPECIES", 157, 165], ["children", "SPECIES", 167, 175], ["common viral pathogens", "PROBLEM", 77, 99], ["prolonged virus shedding", "PROBLEM", 241, 265], ["serious complications", "PROBLEM", 299, 320], ["serious", "OBSERVATION_MODIFIER", 299, 306], ["complications", "OBSERVATION", 307, 320]]], ["Such tests allow detecting agents not primarily expected in a patient.DiscussionAnother important aspect of the identi fi cation of mixed infections is that the presence of more than one pathogen may in fl uence the course of infection; although the exact clinical signi fi cance of mixed infection remains unclear .", [["infections", "DISEASE", 138, 148], ["infection", "DISEASE", 226, 235], ["infection", "DISEASE", 289, 298], ["patient", "ORGANISM", 62, 69], ["patient", "SPECIES", 62, 69], ["Such tests", "TEST", 0, 10], ["mixed infections", "PROBLEM", 132, 148], ["infection", "PROBLEM", 226, 235], ["mixed infection", "PROBLEM", 283, 298], ["mixed", "OBSERVATION_MODIFIER", 132, 137], ["infections", "OBSERVATION", 138, 148], ["infection", "OBSERVATION", 226, 235], ["mixed", "OBSERVATION_MODIFIER", 283, 288], ["infection", "OBSERVATION", 289, 298]]], ["In numerous studies that have described co-infections, no clinical differences among patients with single and multiple infections are reported, including the severity of disease, clinical signs of infection, their intensity, or duration of hospital stays (Brouard et al. 2000 ; Lee et al. 2010 ; Nascimento et al. 2010 ) .", [["infections", "DISEASE", 119, 129], ["infection", "DISEASE", 197, 206], ["patients", "ORGANISM", 85, 93], ["patients", "SPECIES", 85, 93], ["numerous studies", "TEST", 3, 19], ["co-infections", "PROBLEM", 40, 53], ["single and multiple infections", "PROBLEM", 99, 129], ["disease", "PROBLEM", 170, 177], ["infection", "PROBLEM", 197, 206], ["co-infections", "OBSERVATION", 40, 53], ["multiple", "OBSERVATION_MODIFIER", 110, 118], ["infections", "OBSERVATION", 119, 129], ["disease", "OBSERVATION", 170, 177], ["infection", "OBSERVATION", 197, 206]]], ["In contrast, Calvo et al. ( 2008 ) reported that infants with co-infections of RSV and one or more other respiratory pathogens have a signi fi cantly higher incidence of fever and the duration of hospitalization was longer in comparison to infants infected only with RSV.", [["co-infections", "DISEASE", 62, 75], ["RSV", "DISEASE", 79, 82], ["fever", "DISEASE", 170, 175], ["infants", "ORGANISM", 49, 56], ["RSV", "ORGANISM", 79, 82], ["infants", "ORGANISM", 240, 247], ["RSV", "ORGANISM", 267, 270], ["infants", "SPECIES", 49, 56], ["infants", "SPECIES", 240, 247], ["RSV", "SPECIES", 79, 82], ["RSV", "SPECIES", 267, 270], ["co-infections of RSV", "PROBLEM", 62, 82], ["more other respiratory pathogens", "PROBLEM", 94, 126], ["fever", "PROBLEM", 170, 175], ["RSV", "PROBLEM", 267, 270], ["RSV", "OBSERVATION", 79, 82], ["fever", "OBSERVATION", 170, 175]]], ["In the study of Richard et al. ( 2008 ) , a signi fi cant correlation between dual viral infection and increased severity in bronchiolitis was found and infants with co-infections were at 2.7 times higher risk for admission to the pediatric intensive care unit than those with single infections.", [["viral infection", "DISEASE", 83, 98], ["bronchiolitis", "DISEASE", 125, 138], ["co-infections", "DISEASE", 166, 179], ["infections", "DISEASE", 284, 294], ["infants", "ORGANISM", 153, 160], ["infants", "SPECIES", 153, 160], ["a signi fi cant correlation", "PROBLEM", 42, 69], ["dual viral infection", "PROBLEM", 78, 98], ["increased severity", "PROBLEM", 103, 121], ["bronchiolitis", "PROBLEM", 125, 138], ["co-infections", "PROBLEM", 166, 179], ["single infections", "PROBLEM", 277, 294], ["viral", "OBSERVATION_MODIFIER", 83, 88], ["infection", "OBSERVATION", 89, 98], ["increased", "OBSERVATION_MODIFIER", 103, 112], ["severity", "OBSERVATION_MODIFIER", 113, 121], ["bronchiolitis", "OBSERVATION", 125, 138], ["infections", "OBSERVATION", 284, 294]]], ["The other signi fi cant factors that bore on the severity of infection were: age (<42 days), premature birth, and the underlying chronic disease.", [["infection", "DISEASE", 61, 70], ["premature birth", "DISEASE", 93, 108], ["signi fi cant factors", "PROTEIN", 10, 31], ["The other signi fi cant factors", "PROBLEM", 0, 31], ["infection", "PROBLEM", 61, 70], ["premature birth", "PROBLEM", 93, 108], ["the underlying chronic disease", "PROBLEM", 114, 144], ["infection", "OBSERVATION", 61, 70], ["chronic", "OBSERVATION_MODIFIER", 129, 136], ["disease", "OBSERVATION", 137, 144]]], ["There were no statistically signi fi cant differences between host conditions, duration of assisted ventilation or of supplemental oxygen administration, and duration of hospitalization .", [["oxygen", "CHEMICAL", 131, 137], ["oxygen", "CHEMICAL", 131, 137], ["oxygen", "SIMPLE_CHEMICAL", 131, 137], ["statistically signi fi cant differences", "PROBLEM", 14, 53], ["assisted ventilation", "TREATMENT", 91, 111], ["supplemental oxygen administration", "TREATMENT", 118, 152], ["no", "UNCERTAINTY", 11, 13]]], ["Certainly, further studies for a better understanding of these various interactions and the clinical differences between single and multiple respiratory viral infections need to be carried out.", [["respiratory viral infections", "DISEASE", 141, 169], ["further studies", "TEST", 11, 26], ["these various interactions", "PROBLEM", 57, 83], ["multiple respiratory viral infections", "PROBLEM", 132, 169], ["viral infections", "OBSERVATION", 153, 169]]], ["Brunstein et al. ( 2008 ) suggested the occurrence of pathogen co-suppression, when infection with one pathogen reduces a risk for infection with others.", [["infection", "DISEASE", 84, 93], ["infection", "DISEASE", 131, 140], ["pathogen co-suppression", "PROBLEM", 54, 77], ["infection", "PROBLEM", 84, 93], ["one pathogen", "PROBLEM", 99, 111], ["infection", "PROBLEM", 131, 140], ["infection", "OBSERVATION", 131, 140]]], ["Such interactions have been observed for the following viruses: RSV and IV; RSV-A and RSV-B; RSV and PIV; hRV and RSV/IV.", [["RSV", "ORGANISM", 64, 67], ["RSV-A", "ORGANISM", 76, 81], ["RSV-B", "ORGANISM", 86, 91], ["RSV", "ORGANISM", 93, 96], ["PIV", "ORGANISM", 101, 104], ["hRV", "ORGANISM", 106, 109], ["RSV/IV", "ORGANISM", 114, 120], ["RSV", "SPECIES", 93, 96], ["RSV", "SPECIES", 64, 67], ["RSV-A", "SPECIES", 76, 81], ["RSV-B", "SPECIES", 86, 91], ["RSV", "SPECIES", 93, 96], ["PIV", "SPECIES", 101, 104], ["hRV", "SPECIES", 106, 109], ["RSV", "SPECIES", 114, 117], ["RSV", "PROBLEM", 64, 67], ["IV", "TREATMENT", 72, 74], ["RSV", "TREATMENT", 76, 79], ["RSV", "PROBLEM", 93, 96], ["PIV", "TREATMENT", 101, 104], ["hRV", "TREATMENT", 106, 109], ["RSV/IV", "TREATMENT", 114, 120], ["RSV", "ANATOMY", 93, 96], ["PIV", "ANATOMY", 101, 104], ["RSV", "ANATOMY", 114, 117]]], ["However, in the present study we identi fi ed four cases of simultaneous infections with RSV and IV.", [["infections", "DISEASE", 73, 83], ["RSV", "DISEASE", 89, 92], ["RSV", "ORGANISM", 89, 92], ["RSV", "SPECIES", 89, 92], ["simultaneous infections", "PROBLEM", 60, 83], ["RSV", "TREATMENT", 89, 92], ["IV", "TREATMENT", 97, 99], ["simultaneous", "OBSERVATION_MODIFIER", 60, 72], ["infections", "OBSERVATION", 73, 83]]], ["Two of these cases were caused by RSV-A and RSV-B and one by both types of RSV and PIV.", [["RSV-A", "ORGANISM", 34, 39], ["RSV-B", "ORGANISM", 44, 49], ["RSV", "ORGANISM", 75, 78], ["RSV-A", "SPECIES", 34, 39], ["RSV-B", "SPECIES", 44, 49], ["RSV", "SPECIES", 75, 78], ["RSV", "PROBLEM", 34, 37], ["RSV", "TREATMENT", 75, 78], ["PIV", "TREATMENT", 83, 86], ["RSV", "OBSERVATION", 34, 37], ["RSV", "OBSERVATION", 75, 78], ["PIV", "OBSERVATION", 83, 86]]], ["These four co-infected patients (P1, P2, P3 and P4) were hospitalized in the same unit, multiple infections were caused by four different combinations of only six viruses (IV-A in four patients, IV-B in two patients, RSV-A in four patients, RSV-B in three patients, hCoV OC43 in two patients, and PIV-3 in one patient) and all specimens were collected during 1 week, which all suggests a high probability of nosocomial transmissions.", [["specimens", "ANATOMY", 327, 336], ["infections", "DISEASE", 97, 107], ["RSV-B", "DISEASE", 241, 246], ["patients", "ORGANISM", 23, 31], ["IV-A", "ORGANISM", 172, 176], ["patients", "ORGANISM", 185, 193], ["IV-B", "ORGANISM", 195, 199], ["patients", "ORGANISM", 207, 215], ["RSV-A", "ORGANISM", 217, 222], ["patients", "ORGANISM", 231, 239], ["RSV-B", "ORGANISM", 241, 246], ["patients", "ORGANISM", 256, 264], ["hCoV OC43", "ORGANISM", 266, 275], ["patients", "ORGANISM", 283, 291], ["patient", "ORGANISM", 310, 317], ["patients", "SPECIES", 23, 31], ["patients", "SPECIES", 185, 193], ["patients", "SPECIES", 207, 215], ["RSV", "SPECIES", 217, 220], ["patients", "SPECIES", 231, 239], ["RSV", "SPECIES", 241, 244], ["patients", "SPECIES", 256, 264], ["patients", "SPECIES", 283, 291], ["patient", "SPECIES", 310, 317], ["RSV-A", "SPECIES", 217, 222], ["RSV-B", "SPECIES", 241, 246], ["hCoV", "SPECIES", 266, 270], ["multiple infections", "PROBLEM", 88, 107], ["IV-B", "TREATMENT", 195, 199], ["RSV", "TEST", 217, 220], ["RSV", "PROBLEM", 241, 244], ["PIV", "TREATMENT", 297, 300], ["all specimens", "TEST", 323, 336], ["nosocomial transmissions", "PROBLEM", 408, 432], ["co-infected", "OBSERVATION", 11, 22], ["multiple", "OBSERVATION_MODIFIER", 88, 96], ["infections", "OBSERVATION", 97, 107], ["nosocomial transmissions", "OBSERVATION", 408, 432]]], ["Additionally, in the case of Patient 2, the second specimen collected after an interval of 19 days was negative for IV-A and RSV-A but positive for RSV-B.DiscussionThe present study has some limitation.", [["specimen", "ANATOMY", 51, 59], ["RSV-B.Discussion", "CHEMICAL", 148, 164], ["IV-A", "GENE_OR_GENE_PRODUCT", 116, 120], ["RSV-A", "CANCER", 125, 130], ["RSV", "ORGANISM", 148, 151], ["Patient", "SPECIES", 29, 36], ["RSV-A", "SPECIES", 125, 130], ["RSV-B.Discussion", "SPECIES", 148, 164], ["the second specimen", "TEST", 40, 59], ["IV", "TEST", 116, 118], ["RSV", "PROBLEM", 125, 128], ["RSV", "PROBLEM", 148, 151], ["The present study", "TEST", 164, 181]]], ["In electrophoretic gel patterns of PCR products obtained for patients with co-infections, the intensity of bands was variable, with some faint bands.", [["co-infections", "DISEASE", 75, 88], ["patients", "ORGANISM", 61, 69], ["PCR products", "PROTEIN", 35, 47], ["patients", "SPECIES", 61, 69], ["PCR products", "TREATMENT", 35, 47], ["co-infections", "PROBLEM", 75, 88], ["the intensity of bands", "PROBLEM", 90, 112], ["some faint bands", "PROBLEM", 132, 148], ["faint", "OBSERVATION_MODIFIER", 137, 142], ["bands", "OBSERVATION", 143, 148]]], ["Due to excellent sensitivity of PCR and its very low detection limit (even several copies per reaction, including non-replicated viruses), weak positive results may be related not with active but passing infection (Calvo et al. 2008 ) .", [["infection", "DISEASE", 204, 213], ["PCR", "TEST", 32, 35], ["its very low detection limit", "PROBLEM", 40, 68], ["non-replicated viruses", "PROBLEM", 114, 136], ["weak positive results", "PROBLEM", 139, 160], ["passing infection", "PROBLEM", 196, 213], ["infection", "OBSERVATION", 204, 213]]], ["Especially in children and immunosuppressed patients, shedding of a low concentration of viruses from a previous infection would be expected.", [["infection", "DISEASE", 113, 122], ["children", "ORGANISM", 14, 22], ["patients", "ORGANISM", 44, 52], ["children", "SPECIES", 14, 22], ["patients", "SPECIES", 44, 52], ["a low concentration of viruses", "PROBLEM", 66, 96], ["a previous infection", "PROBLEM", 102, 122], ["immunosuppressed", "OBSERVATION", 27, 43], ["low concentration", "OBSERVATION_MODIFIER", 68, 85], ["viruses", "OBSERVATION", 89, 96], ["infection", "OBSERVATION", 113, 122]]], ["This may be relevant for the interpretation of multiple infections and for the role of particular pathogens in the clinical picture of disease.", [["infections", "DISEASE", 56, 66], ["multiple infections", "PROBLEM", 47, 66], ["particular pathogens", "PROBLEM", 87, 107], ["disease", "PROBLEM", 135, 142], ["multiple", "OBSERVATION_MODIFIER", 47, 55], ["infections", "OBSERVATION", 56, 66]]], ["The identi fi ed presence of viral agents does not exclude the possibility of concomitant infection caused by bacterial pathogens.", [["infection", "DISEASE", 90, 99], ["viral agents", "TREATMENT", 29, 41], ["concomitant infection", "PROBLEM", 78, 99], ["bacterial pathogens", "PROBLEM", 110, 129], ["viral", "OBSERVATION", 29, 34], ["concomitant", "OBSERVATION_MODIFIER", 78, 89], ["infection", "OBSERVATION", 90, 99], ["bacterial pathogens", "OBSERVATION", 110, 129]]], ["In our study, in Patients 2, 3, and 4 cultures of bronchial secretion or sputum gave all negative results.", [["bronchial", "ANATOMY", 50, 59], ["sputum", "ANATOMY", 73, 79], ["Patients", "ORGANISM", 17, 25], ["bronchial", "MULTI-TISSUE_STRUCTURE", 50, 59], ["sputum", "ORGANISM_SUBSTANCE", 73, 79], ["Patients", "SPECIES", 17, 25], ["our study", "TEST", 3, 12], ["4 cultures", "TEST", 36, 46], ["bronchial secretion", "PROBLEM", 50, 69], ["sputum", "TEST", 73, 79], ["bronchial", "ANATOMY", 50, 59]]], ["In Patient 1, culture of bronchial secretion was positive for Acinetobacter baumanii and in Patient 5 it was positive for Streptococcus pneumoniae but that from a throat swab was negative.ConclusionsIn conclusion, our fi ndings show that in case of hospitalized patients with respiratory tract infection, especially with severe infections observed in children, elderly, and immunocompromised patients who are susceptible to serious complications, the simultaneous detection of multiple viral agents is advisable and more reliable than detection of only in fl uenza viruses.", [["bronchial", "ANATOMY", 25, 34], ["throat swab", "ANATOMY", 163, 174], ["respiratory tract", "ANATOMY", 276, 293], ["Acinetobacter baumanii", "DISEASE", 62, 84], ["Streptococcus pneumoniae", "DISEASE", 122, 146], ["respiratory tract infection", "DISEASE", 276, 303], ["infections", "DISEASE", 328, 338], ["bronchial", "ORGAN", 25, 34], ["Acinetobacter baumanii", "ORGANISM", 62, 84], ["Streptococcus pneumoniae", "ORGANISM", 122, 146], ["patients", "ORGANISM", 262, 270], ["tract", "ORGANISM_SUBDIVISION", 288, 293], ["children", "ORGANISM", 351, 359], ["patients", "ORGANISM", 392, 400], ["fl uenza viruses", "ORGANISM", 556, 572], ["Patient", "SPECIES", 3, 10], ["Acinetobacter baumanii", "SPECIES", 62, 84], ["Patient", "SPECIES", 92, 99], ["Streptococcus pneumoniae", "SPECIES", 122, 146], ["patients", "SPECIES", 262, 270], ["children", "SPECIES", 351, 359], ["patients", "SPECIES", 392, 400], ["Acinetobacter baumanii", "SPECIES", 62, 84], ["Streptococcus pneumoniae", "SPECIES", 122, 146], ["culture of bronchial secretion", "TEST", 14, 44], ["Acinetobacter baumanii", "PROBLEM", 62, 84], ["Streptococcus pneumoniae", "PROBLEM", 122, 146], ["a throat swab", "TEST", 161, 174], ["our fi ndings", "TEST", 214, 227], ["respiratory tract infection", "PROBLEM", 276, 303], ["severe infections", "PROBLEM", 321, 338], ["serious complications", "PROBLEM", 424, 445], ["multiple viral agents", "TREATMENT", 477, 498], ["fl uenza viruses", "PROBLEM", 556, 572], ["bronchial", "ANATOMY", 25, 34], ["Streptococcus pneumoniae", "OBSERVATION", 122, 146], ["throat", "ANATOMY", 163, 169], ["respiratory tract", "ANATOMY", 276, 293], ["infection", "OBSERVATION", 294, 303], ["severe", "OBSERVATION_MODIFIER", 321, 327], ["infections", "OBSERVATION", 328, 338], ["multiple", "OBSERVATION_MODIFIER", 477, 485], ["viral", "OBSERVATION", 486, 491], ["fl uenza viruses", "OBSERVATION", 556, 572]]], ["This enables to reveal an accurate picture of the disease and thus is essential for the control of infection, including the nosocomial transmission, prioritizing diagnostic and improvement of both preventive and therapeutic managements.", [["infection", "DISEASE", 99, 108], ["the disease", "PROBLEM", 46, 57], ["infection", "PROBLEM", 99, 108], ["the nosocomial transmission", "PROBLEM", 120, 147], ["therapeutic managements", "TREATMENT", 212, 235], ["disease", "OBSERVATION", 50, 57], ["infection", "OBSERVATION", 99, 108]]], ["Identifying the accurate etiology of infection also allows the physician to determine better prognosis and to inform patients about the measures that should be implemented to limit the spread of infections to other persons.Con fl icts of interest :The authors declare no con fl icts of interest in relation to this article.", [["infection", "DISEASE", 37, 46], ["infections", "DISEASE", 195, 205], ["patients", "ORGANISM", 117, 125], ["persons", "ORGANISM", 215, 222], ["patients", "SPECIES", 117, 125], ["persons", "SPECIES", 215, 222], ["infection", "PROBLEM", 37, 46], ["infection", "OBSERVATION", 37, 46]]]], "39d0a71cc434fd37bb3fc873c2c52cb1b69eb5c3": [], "7b4204361f4555c47515ecf6c6f55fdafdc3e279": [["with similar clinical diagnosis and based on epidemiological risk factors, with a spatial separation.", [["epidemiological risk factors", "PROBLEM", 45, 73], ["a spatial separation", "PROBLEM", 80, 100], ["spatial separation", "OBSERVATION", 82, 100]]], ["Special populations to consider include the elderly, children, women who are pregnant, persons with disabling mental or physical illnesses, and communications impaired persons. **Elderly physiology -depending upon a variety of host factors, may have suppressed immune systems compared with younger patients.", [["children", "ORGANISM", 53, 61], ["women", "ORGANISM", 63, 68], ["persons", "ORGANISM", 168, 175], ["patients", "ORGANISM", 298, 306], ["children", "SPECIES", 53, 61], ["women", "SPECIES", 63, 68], ["persons", "SPECIES", 87, 94], ["persons", "SPECIES", 168, 175], ["patients", "SPECIES", 298, 306], ["disabling mental or physical illnesses", "PROBLEM", 100, 138], ["Elderly physiology", "PROBLEM", 179, 197], ["suppressed immune systems", "PROBLEM", 250, 275]]], ["Also this demographic may present with varying levels of hearing, or cognitive loss, as well as delirium.", [["cognitive loss", "DISEASE", 69, 83], ["delirium", "DISEASE", 96, 104], ["varying levels of hearing", "PROBLEM", 39, 64], ["cognitive loss", "PROBLEM", 69, 83], ["delirium", "PROBLEM", 96, 104]]], ["This can be confounding since some older patients may have Alzheimer's or other cognitive limiting disease process, or have medications prescribed to them for various comorbid conditions, which can cause some loss of intellectual function.", [["Alzheimer's or other cognitive limiting disease process", "DISEASE", 59, 114], ["loss of intellectual function", "DISEASE", 209, 238], ["patients", "ORGANISM", 41, 49], ["patients", "SPECIES", 41, 49], ["Alzheimer's", "PROBLEM", 59, 70], ["other cognitive limiting disease process", "PROBLEM", 74, 114], ["medications", "TREATMENT", 124, 135], ["various comorbid conditions", "PROBLEM", 159, 186], ["some loss of intellectual function", "PROBLEM", 204, 238]]], ["Moreover physiologically it is well known that aging can blunt the febrile response, such that the absence of fever (34) (35) (36) should not automatically dissuade the clinician from considering COVID-19 or other pathogen mediated infection.", [["febrile", "DISEASE", 67, 74], ["fever", "DISEASE", 110, 115], ["infection", "DISEASE", 232, 241], ["COVID-19", "GENE_OR_GENE_PRODUCT", 196, 204], ["the febrile response", "PROBLEM", 63, 83], ["fever", "PROBLEM", 110, 115], ["COVID", "TEST", 196, 201], ["other pathogen mediated infection", "PROBLEM", 208, 241], ["infection", "OBSERVATION", 232, 241]]]]}